<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Schizophrenia Spectrum Disorders - Psychology Presentation</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Inter', sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
            overflow: hidden;
        }

        .presentation-container {
            width: 100%;
            height: 100vh;
            display: flex;
            align-items: center;
            justify-content: center;
            position: relative;
        }

        .slide {
            width: 90%;
            max-width: 1200px;
            height: 85vh;
            background: white;
            border-radius: 20px;
            box-shadow: 0 25px 50px -12px rgba(0, 0, 0, 0.25);
            padding: 60px;
            position: absolute;
            opacity: 0;
            transform: translateX(100%);
            transition: all 0.6s cubic-bezier(0.68, -0.55, 0.265, 1.55);
            overflow-y: auto;
        }

        .slide.active {
            opacity: 1;
            transform: translateX(0);
        }

        .slide.prev {
            transform: translateX(-100%);
        }

        h1 {
            color: #5B21B6;
            font-size: 2.5em;
            margin-bottom: 20px;
            font-weight: 700;
        }

        h2 {
            color: #6D28D9;
            font-size: 2em;
            margin-bottom: 20px;
            font-weight: 600;
        }

        h3 {
            color: #7C3AED;
            font-size: 1.5em;
            margin-bottom: 15px;
            font-weight: 600;
        }

        p {
            color: #4B5563;
            line-height: 1.8;
            margin-bottom: 15px;
            font-size: 1.1em;
        }

        .navigation {
            position: fixed;
            bottom: 40px;
            left: 50%;
            transform: translateX(-50%);
            display: flex;
            gap: 20px;
            z-index: 1000;
        }

        .nav-btn {
            background: #7C3AED;
            color: white;
            border: none;
            padding: 15px 30px;
            border-radius: 50px;
            font-size: 16px;
            cursor: pointer;
            transition: all 0.3s ease;
            box-shadow: 0 4px 15px rgba(124, 58, 237, 0.3);
        }

        .nav-btn:hover {
            background: #6D28D9;
            transform: translateY(-2px);
            box-shadow: 0 6px 20px rgba(124, 58, 237, 0.4);
        }

        .nav-btn:disabled {
            background: #D1D5DB;
            cursor: not-allowed;
            box-shadow: none;
        }

        .slide-number {
            position: absolute;
            top: 30px;
            right: 30px;
            background: #EDE9FE;
            color: #7C3AED;
            padding: 10px 20px;
            border-radius: 20px;
            font-weight: 600;
        }

        .chart-container {
            width: 100%;
            max-width: 600px;
            margin: 30px auto;
            padding: 20px;
            background: #F9FAFB;
            border-radius: 15px;
        }

        .image-placeholder {
            width: 100%;
            max-width: 500px;
            height: 300px;
            background: linear-gradient(135deg, #E0E7FF 0%, #C7D2FE 100%);
            border-radius: 15px;
            display: flex;
            align-items: center;
            justify-content: center;
            margin: 20px auto;
            font-size: 1.2em;
            color: #6D28D9;
            text-align: center;
            padding: 20px;
        }

        .two-column {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 40px;
            align-items: start;
        }

        .highlight-box {
            background: #F3F4F6;
            border-left: 4px solid #7C3AED;
            padding: 20px;
            margin: 20px 0;
            border-radius: 0 10px 10px 0;
        }

        .stat-box {
            background: linear-gradient(135deg, #EDE9FE 0%, #DDD6FE 100%);
            padding: 30px;
            border-radius: 15px;
            text-align: center;
            margin: 10px;
        }

        .stat-number {
            font-size: 3em;
            color: #7C3AED;
            font-weight: 700;
        }

        .stat-label {
            color: #6B7280;
            margin-top: 10px;
        }

        .button-group {
            display: flex;
            gap: 15px;
            margin: 30px 0;
            flex-wrap: wrap;
        }

        .info-btn {
            background: #7C3AED;
            color: white;
            border: none;
            padding: 12px 25px;
            border-radius: 25px;
            cursor: pointer;
            transition: all 0.3s ease;
            font-size: 14px;
            font-weight: 500;
        }

        .info-btn:hover {
            background: #6D28D9;
            transform: translateY(-2px);
            box-shadow: 0 4px 15px rgba(124, 58, 237, 0.3);
        }

        ul {
            list-style: none;
            padding-left: 0;
        }

        ul li {
            padding: 10px 0;
            padding-left: 30px;
            position: relative;
            color: #4B5563;
            line-height: 1.6;
        }

        ul li:before {
            content: "â–¸";
            position: absolute;
            left: 0;
            color: #7C3AED;
            font-weight: bold;
        }

        .timeline {
            position: relative;
            padding: 20px 0;
        }

        .timeline-item {
            position: relative;
            padding-left: 40px;
            margin-bottom: 30px;
        }

        .timeline-item:before {
            content: "";
            position: absolute;
            left: 8px;
            top: 8px;
            width: 16px;
            height: 16px;
            background: #7C3AED;
            border-radius: 50%;
        }

        .timeline-item:after {
            content: "";
            position: absolute;
            left: 15px;
            top: 24px;
            width: 2px;
            height: calc(100% + 14px);
            background: #E5E7EB;
        }

        .timeline-item:last-child:after {
            display: none;
        }

        .reference {
            font-size: 0.9em;
            color: #6B7280;
            margin: 5px 0;
            padding-left: 20px;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .fade-in {
            animation: fadeIn 0.6s ease-out;
        }

        .progress-bar {
            position: fixed;
            top: 0;
            left: 0;
            height: 4px;
            background: #7C3AED;
            transition: width 0.3s ease;
            z-index: 1001;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            border-radius: 10px;
            overflow: hidden;
        }

        th {
            background: #7C3AED;
            color: white;
            padding: 15px;
            text-align: left;
            font-weight: 600;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #E5E7EB;
        }

        tr:nth-child(even) {
            background: #F9FAFB;
        }

        .icon-box {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 60px;
            height: 60px;
            background: #EDE9FE;
            border-radius: 15px;
            margin-bottom: 20px;
            color: #7C3AED;
            font-size: 24px;
        }
        .modal {
        display: none;
        position: fixed;
        z-index: 2000;
        left: 0;
        top: 0;
        width: 100%;
        height: 100%;
        background-color: rgba(0,0,0,0.5);
        }

    .modal-content {
        background-color: white;
        margin: 5% auto;
        padding: 40px;
        border-radius: 20px;
        width: 80%;
        max-width: 800px;
        max-height: 80vh;
        overflow-y: auto;
        box-shadow: 0 25px 50px -12px rgba(0, 0, 0, 0.25);
    }

    .close {
        color: #aaa;
        float: right;
        font-size: 28px;
        font-weight: bold;
        cursor: pointer;
    }

    .close:hover {
        color: #7C3AED;
    }

    </style>
</head>
<body>
    <div id="modal" class="modal">
        <div class="modal-content">
            <span class="close">&times;</span>
            <h2 id="modalTitle"></h2>
            <div id="modalBody"></div>
        </div>
    </div>
    <div class="progress-bar" id="progressBar"></div>
    
    <div class="presentation-container">
        <!-- Slide 1: Title Slide -->
        <div class="slide active">
            <div class="slide-number">1 / 20</div>
            <div style="text-align: center; margin-top: 100px;">
                <div class="icon-box" style="margin: 0 auto 30px;">
                    <i class="fas fa-brain"></i>
                </div>
                <h1 style="font-size: 3.5em; margin-bottom: 30px;">Schizophrenia Spectrum Disorders</h1>
                <p style="font-size: 1.5em; color: #6B7280; margin-bottom: 40px;">Understanding the Complexity of Psychotic Disorders</p>
                <div class="button-group" style="justify-content: center;">
                    <button class="info-btn"><i class="fas fa-graduation-cap"></i> Psychology Class [SUNY]</button>
                    <button class="info-btn" onclick="alert('srijandsofficial@gmail.com/ssrijandev@gmail.com')"><i class="fas fa-calendar"></i> Email Me
                        </button>
                    
                </div>
                <div class="image-placeholder" style="margin-top: 50px;">
                    <img src="https://i0.wp.com/post.healthline.com/wp-content/uploads/2022/03/Schizophrenia-PET-Scan-body-1.jpg?w=1155&h=1528" 
                         alt="Brain MRI" 
                         style="width: 100%; height: auto; border-radius: 15px; margin-top: 20px;">
                    
                </div>
            </div>
        </div>

        <!-- Slide 2: Overview -->
        <div class="slide">
            <div class="slide-number">2 / 20</div>
            <h1>Overview of Presentation</h1>
            <div class="two-column">
                <div>
                    <h3>What We'll Cover:</h3>
                    <ul>
                        <li>Definition and History</li>
                        <li>Types of Schizophrenia Spectrum Disorders</li>
                        <li>Symptoms and Diagnosis</li>
                        <li>Neurobiological Factors</li>
                        <li>Treatment Approaches</li>
                        <li>Recent Research Findings</li>
                        <li>Case Studies</li>
                        <li>Future Directions</li>
                    </ul>
                </div>
                <div>
                    <div class="highlight-box">
                        <h3><i class="fas fa-lightbulb"></i> Learning Objectives</h3>
                        <p>By the end of this presentation, you will:</p>
                        <ul>
                            <li>Understand the diagnostic criteria</li>
                            <li>Recognize different types and symptoms</li>
                            <li>Know current treatment options</li>
                            <li>Be aware of recent research developments</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 3: Definition -->
        <div class="slide">
            <div class="slide-number">3 / 20</div>
            <h1>What is Schizophrenia?</h1>
            <div class="highlight-box">
                <p><strong>Definition:</strong> Schizophrenia is a chronic brain disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may experience hallucinations, delusions, and extremely disordered thinking.</p>
            </div>
            <div class="two-column" style="margin-top: 40px;">
                <div>
                    <h3>Key Characteristics:</h3>
                    <ul>
                        <li>Distortions in thinking</li>
                        <li>Distortions in perception</li>
                        <li>Distortions in emotions</li>
                        <li>Distortions in language</li>
                        <li>Distortions in sense of self</li>
                        <li>Distortions in behavior</li>
                    </ul>
                </div>
                <div>
                    <div class="stat-box">
                        <div class="stat-number">1%</div>
                        <div class="stat-label">of the population affected worldwide</div>
                    </div>
                    <div class="stat-box" style="margin-top: 20px;">
                        <div class="stat-number">20-30</div>
                        <div class="stat-label">Typical age of onset (years)</div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 4: Historical Perspective -->
        <div class="slide">
            <div class="slide-number">4 / 20</div>
            <h1>Historical Perspective</h1>
            <div class="timeline">
                <div class="timeline-item">
                    <h3>1887 - Emil Kraepelin</h3>
                    <p>First described "dementia praecox" - a progressive deteriorating psychotic disorder</p>
                </div>
                <div class="timeline-item">
                    <h3>1911 - Eugen Bleuler</h3>
                    <p>Coined the term "schizophrenia" meaning "split mind"</p>
                </div>
                <div class="timeline-item">
                    <h3>1950s - First Antipsychotics</h3>
                    <p>Chlorpromazine revolutionized treatment</p>
                </div>
                <div class="timeline-item">
                    <h3>1980 - DSM-III</h3>
                    <p>Standardized diagnostic criteria established</p>
                </div>
                <div class="timeline-item">
                    <h3>2013 - DSM-5</h3>
                    <p>Introduction of Schizophrenia Spectrum concept</p>
                </div>
            </div>
            <div class="button-group">
                <button class="info-btn"onclick="openLink('https://livingwithschizophreniauk.org/information-sheets/schizophrenia-a-brief-history/#:~:text=Swiss%20psychiatrist%20Eugen%20Bleuler%20who,a%20distinct%20improvement%20over%20time.')">
                    <i class="fas fa-book"></i> Learn More History</button>
                <button class="info-btn"onclick="openLink('https://en.wikipedia.org/wiki/History_of_schizophrenia')">
                    <i class="fas fa-user-md"></i> Key Researchers</button>
            </div>
        </div>

        <!-- Slide 5: Types of Schizophrenia Spectrum Disorders -->
        <div class="slide">
            <div class="slide-number">5 / 20</div>
            <h1>Schizophrenia Spectrum Disorders</h1>
            <table>
                <thead>
                    <tr>
                        <th>Disorder</th>
                        <th>Duration</th>
                        <th>Key Features</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Schizotypal Personality Disorder</strong></td>
                        <td>Lifelong pattern</td>
                        <td>Odd beliefs, behavior, and speech</td>
                    </tr>
                    <tr>
                        <td><strong>Delusional Disorder</strong></td>
                        <td>â‰¥1 month</td>
                        <td>Fixed false beliefs without other symptoms</td>
                    </tr>
                    <tr>
                        <td><strong>Brief Psychotic Disorder</strong></td>
                        <td>1 day - 1 month</td>
                        <td>Sudden onset, often stress-related</td>
                    </tr>
                    <tr>
                        <td><strong>Schizophreniform Disorder</strong></td>
                        <td>1-6 months</td>
                        <td>Same as schizophrenia but shorter</td>
                    </tr>
                    <tr>
                        <td><strong>Schizophrenia</strong></td>
                        <td>â‰¥6 months</td>
                        <td>Full syndrome with functional decline</td>
                    </tr>
                    <tr>
                        <td><strong>Schizoaffective Disorder</strong></td>
                        <td>Variable</td>
                        <td>Schizophrenia + mood episodes</td>
                    </tr>
                </tbody>
            </table>
            <div class="chart-container">
                <canvas id="spectrumChart"></canvas>
            </div>
        </div>

        <!-- Slide 6: Positive Symptoms -->
        <div class="slide">
            <div class="slide-number">6 / 20</div>
            <h1>Positive Symptoms</h1>
            <p style="font-style: italic; color: #7C3AED;">Experiences that are "added" to normal functioning</p>
            <div class="two-column">
                <div>
                    <div class="icon-box">
                        <i class="fas fa-eye"></i>
                    </div>
                    <h3>Hallucinations</h3>
                    <ul>
                        <li>Auditory (most common - 70%)</li>
                        <li>Visual (15-20%)</li>
                        <li>Tactile (feeling sensations)</li>
                        <li>Olfactory (smelling odors)</li>
                        <li>Gustatory (tasting)</li>
                    </ul>
                    
                    <div class="icon-box" style="margin-top: 30px;">
                        <i class="fas fa-comments"></i>
                    </div>
                    <h3>Disorganized Speech</h3>
                    <ul>
                        <li>Loose associations</li>
                        <li>Tangential thinking</li>
                        <li>Word salad</li>
                        <li>Neologisms</li>
                    </ul>
                </div>
                <div>
                    <div class="icon-box">
                        <i class="fas fa-head-side-virus"></i>
                    </div>
                    <h3>Delusions</h3>
                    <ul>
                        <li>Persecutory (most common)</li>
                        <li>Referential</li>
                        <li>Grandiose</li>
                        <li>Religious</li>
                        <li>Somatic</li>
                    </ul>
                    
                    <div class="icon-box" style="margin-top: 30px;">
                        <i class="fas fa-running"></i>
                    </div>
                    <h3>Disorganized Behavior</h3>
                    <ul>
                        <li>Unpredictable agitation</li>
                        <li>Bizarre postures</li>
                        <li>Excessive motor activity</li>
                        <li>Echopraxia</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Slide 7: Negative Symptoms -->
        <div class="slide">
            <div class="slide-number">7 / 20</div>
            <h1>Negative Symptoms</h1>
            <p style="font-style: italic; color: #7C3AED;">Absence or reduction of normal functions</p>
            <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 20px; margin-top: 40px;">
                <div class="stat-box">
                    <i class="fas fa-meh" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Affective Flattening</h3>
                    <p>Reduced emotional expression</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-comment-slash" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Alogia</h3>
                    <p>Poverty of speech</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-battery-empty" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Avolition</h3>
                    <p>Lack of motivation</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-frown" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Anhedonia</h3>
                    <p>Inability to experience pleasure</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-user-slash" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Asociality</h3>
                    <p>Social withdrawal</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-brain" style="font-size: 2em; color: #7C3AED; margin-bottom: 10px;"></i>
                    <h3>Cognitive Deficits</h3>
                    <p>Attention & memory issues</p>
                </div>
            </div>
            <div class="chart-container" style="max-width: 400px;">
                <canvas id="symptomsChart"></canvas>
            </div>
        </div>

        <!-- Slide 8: Diagnostic Criteria (DSM-5) -->
        <div class="slide">
            <div class="slide-number">8 / 20</div>
            <h1>DSM-5 Diagnostic Criteria</h1>
            <div class="highlight-box">
                <h3>Criterion A: Two or more of the following for â‰¥1 month:</h3>
                <ol style="padding-left: 20px; color: #4B5563;">
                    <li>Delusions</li>
                    <li>Hallucinations</li>
                    <li>Disorganized speech</li>
                    <li>Grossly disorganized or catatonic behavior</li>
                    <li>Negative symptoms</li>
                </ol>
            </div>
            <div class="two-column" style="margin-top: 30px;">
                <div>
                    <h3>Additional Criteria:</h3>
                    <ul>
                        <li><strong>B:</strong> Significant functional decline</li>
                        <li><strong>C:</strong> Continuous signs for â‰¥6 months</li>
                        <li><strong>D:</strong> Exclusion of other disorders</li>
                        <li><strong>E:</strong> Not due to substances</li>
                        <li><strong>F:</strong> If autism history, prominent delusions/hallucinations required</li>
                    </ul>
                </div>
                <div>
                    <div class="button-group">
                        <button class="info-btn"onclick="showContent('dsm5-checklist')"><i class="fas fa-download"></i> DSM-5 Checklist</button>
                        <button class="info-btn" onclick="downloadDSM5Checklist()"><i class="fas fa-download"></i> Download DSM-5 Checklist</button>
                        <button class="info-btn" onclick="showContent('panss-scale')"><i class="fas fa-stethoscope"></i> PANSS Scale</button>
                        <button class="info-btn" onclick="downloadPANSSForm()"><i class="fas fa-download"></i> Download PANSS Form</button>
                        <button class="info-btn" onclick="showContent('clinical-assessment-tools')">
        <i class="fas fa-stethoscope"></i> Clinical Assessment Tools
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 9: Neurobiological Factors -->
        <div class="slide">
            <div class="slide-number">9 / 20</div>
            <h1>Neurobiological Factors</h1>
            <div class="two-column">
                <div>
                    <h3><i class="fas fa-dna"></i> Genetic Factors</h3>
                    <div class="chart-container">
                        <canvas id="geneticsChart"></canvas>
                    </div>
                    <p>Risk increases with genetic proximity to affected individual</p>
                </div>
                <div>
                    <h3><i class="fas fa-brain"></i> Brain Abnormalities</h3>
                    <ul>
                        <li>Enlarged ventricles</li>
                        <li>Reduced gray matter</li>
                        <li>Frontal lobe dysfunction</li>
                        <li>Temporal lobe abnormalities</li>
                        <li>Hippocampal volume reduction</li>
                    </ul>
                    <div class="highlight-box" style="margin-top: 20px;">
                        <h4>Neurotransmitter Imbalances:</h4>
                        <p>â€¢ Dopamine (excess)<br>
                        â€¢ Glutamate (deficiency)<br>
                        â€¢ GABA (reduced)<br>
                        â€¢ Serotonin (altered)</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 10: Environmental Risk Factors -->
        <div class="slide">
            <div class="slide-number">10 / 20</div>
            <h1>Environmental Risk Factors</h1>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 30px;">
                <div class="highlight-box">
                    <h3><i class="fas fa-baby"></i> Prenatal & Perinatal</h3>
                    <ul>
                        <li>Maternal infections (influenza, toxoplasmosis)</li>
                        <li>Malnutrition during pregnancy</li>
                        <li>Birth complications</li>
                        <li>Low birth weight</li>
                        <li>Hypoxia during delivery</li>
                    </ul>
                </div>
                <div class="highlight-box">
                    <h3><i class="fas fa-city"></i> Environmental Stressors</h3>
                    <ul>
                        <li>Urban upbringing (2-3x risk)</li>
                        <li>Migration stress</li>
                        <li>Social isolation</li>
                        <li>Childhood trauma</li>
                        <li>Cannabis use in adolescence</li>
                    </ul>
                </div>
                <div class="highlight-box">
                    <h3><i class="fas fa-users"></i> Social Factors</h3>
                    <ul>
                        <li>Family dysfunction</li>
                        <li>Expressed emotion (criticism)</li>
                        <li>Social defeat</li>
                        <li>Discrimination</li>
                        <li>Poverty</li>
                    </ul>
                </div>
                <div class="highlight-box">
                    <h3><i class="fas fa-calendar"></i> Timing Factors</h3>
                    <ul>
                        <li>Season of birth (winter/spring)</li>
                        <li>Advanced paternal age</li>
                        <li>Adolescent stress</li>
                        <li>Critical developmental periods</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Slide 11: Treatment Approaches -->
        <div class="slide">
            <div class="slide-number">11 / 20</div>
            <h1>Treatment Approaches</h1>
            <div class="two-column">
                <div>
                    <h3><i class="fas fa-pills"></i> Pharmacological Treatment</h3>
                    <h4>First-Generation Antipsychotics:</h4>
                    <ul>
                        <li>Haloperidol</li>
                        <li>Chlorpromazine</li>
                        <li>Fluphenazine</li>
                    </ul>
                    <h4 style="margin-top: 20px;">Second-Generation Antipsychotics:</h4>
                    <ul>
                        <li>Risperidone</li>
                        <li>Olanzapine</li>
                        <li>Quetiapine</li>
                        <li>Aripiprazole</li>
                        <li>Clozapine (treatment-resistant)</li>
                    </ul>
                </div>
                <div>
                    <h3><i class="fas fa-comments"></i> Psychosocial Interventions</h3>
                    <ul>
                        <li>Cognitive Behavioral Therapy (CBT)</li>
                        <li>Family therapy</li>
                        <li>Social skills training</li>
                        <li>Cognitive remediation</li>
                                                <li>Vocational rehabilitation</li>
                        <li>Assertive Community Treatment (ACT)</li>
                    </ul>
                    <div class="stat-box" style="margin-top: 20px;">
                        <div class="stat-number">70%</div>
                        <div class="stat-label">Response rate with combined treatment</div>
                    </div>
                </div>
            </div>
            <div class="chart-container">
                <canvas id="treatmentChart"></canvas>
            </div>
        </div>

        <!-- Slide 12: Recent Research Study 1 -->
        <div class="slide">
            <div class="slide-number">12 / 20</div>
            <h1>Recent Research: Genetics</h1>
            <div class="highlight-box">
                <h3>Study: Nature (2022) - Schizophrenia Working Group</h3>
                <p><strong>Title:</strong> "Common schizophrenia alleles are enriched in mutation-intolerant genes"</p>
                <p><strong>Sample Size:</strong> 76,755 cases and 243,649 controls</p>
            </div>
            <div class="two-column">
                <div>
                    <h3>Key Findings:</h3>
                    <ul>
                        <li>287 genomic loci associated with schizophrenia</li>
                        <li>120 genes directly implicated</li>
                        <li>Synaptic organization pathways identified</li>
                        <li>Neuronal excitability genes involved</li>
                        <li>10 genes with therapeutic potential</li>
                    </ul>
                </div>
                <div>
                    <div class="chart-container">
                        <canvas id="researchChart1"></canvas>
                    </div>
                    <div class="button-group" style="margin-top: 20px;">
                        <button class="info-btn"onclick="openLink('https://www.nature.com/articles/s41586-022-04434-5')"><i class="fas fa-file-pdf"></i> Full Study</button>
                        <button class="info-btn"onclick="openLink('https://www.ncbi.nlm.nih.gov/gene')"><i class="fas fa-dna"></i> Gene Database</button>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 13: Recent Research Study 2 -->
        <div class="slide">
            <div class="slide-number">13 / 20</div>
            <h1>Recent Research: Brain Imaging</h1>
            <div class="highlight-box">
                <h3>Study: American Journal of Psychiatry (2023)</h3>
                <p><strong>Title:</strong> "Progressive Brain Changes in Schizophrenia: A 10-Year Longitudinal Study"</p>
                <p><strong>Methodology:</strong> MRI scans every 2 years, 189 patients vs 158 controls</p>
            </div>
            <div class="two-column">
                <div>
                    <h3>Brain Volume Changes:</h3>
                    <div class="chart-container">
                        <canvas id="brainChart"></canvas>
                    </div>
                </div>
                <div>
                    <h3>Clinical Implications:</h3>
                    <ul>
                        <li>Early intervention crucial</li>
                        <li>Neuroprotective strategies needed</li>
                        <li>Medication adherence important</li>
                        <li>Cognitive training beneficial</li>
                    </ul>
    <!-- New MRI Comparison Section -->
    <div style="margin-top: 40px;">
        <h3 style="text-align: center; margin-bottom: 20px;">MRI Brain Scan Comparison</h3>
        <div class="mri-comparison">
            <div class="mri-container">
                <h4>Healthy Control</h4>
                <div class="brain-scan healthy">
                    <div class="brain-region ventricles"></div>
                    <div class="brain-region gray-matter"></div>
                    <div class="brain-region white-matter"></div>
                    <div class="scan-label">Normal ventricle size</div>
                    <div class="scan-label bottom">Intact gray matter</div>
                </div>
                <div class="scan-info">
                    <p><i class="fas fa-check-circle" style="color: #10B981;"></i> Normal ventricles</p>
                    <p><i class="fas fa-check-circle" style="color: #10B981;"></i> Preserved gray matter</p>
                    <p><i class="fas fa-check-circle" style="color: #10B981;"></i> Intact hippocampus</p>
                </div>
            </div>                
            
                <h4>Schizophrenia Patient</h4>
                <div class="brain-scan schizophrenia">
                    <div class="brain-region ventricles enlarged"></div>
                    <div class="brain-region gray-matter reduced"></div>
                    <div class="brain-region white-matter"></div>
                    <div class="scan-label">Enlarged ventricles</div>
                    <div class="scan-label bottom">Reduced gray matter</div>
                </div>
                <div class="scan-info">
                    <p><i class="fas fa-exclamation-circle" style="color: #EF4444;"></i> Enlarged ventricles</p>
                    <p><i class="fas fa-exclamation-circle" style="color: #EF4444;"></i> Gray matter loss</p>
                    <p><i class="fas fa-exclamation-circle" style="color: #EF4444;"></i> Hippocampal atrophy</p>
                </div>
            </div>
        </div>
        
        <div class="image-note">
            <p><i class="fas fa-info-circle"></i> <strong>Note:</strong> These are simplified representations. Actual MRI scans would show more detailed structural differences.</p>
        </div>
        
        
                </div>
            </div>
        </div>

        <!-- Slide 14: Case Study 1 -->
        <div class="slide">
            <div class="slide-number">14 / 20</div>
            <h1>Case Study: Early-Onset Schizophrenia</h1>
            <div class="highlight-box">
                <h3>Patient Profile: "James"</h3>
                <p><strong>Age:</strong> 22 years old | <strong>Gender:</strong> Male | <strong>Onset:</strong> Age 18</p>
            </div>
            <div class="timeline">
                <div class="timeline-item">
                    <h4>Age 16-17: Prodromal Phase</h4>
                    <p>Social withdrawal, declining grades, unusual beliefs about classmates</p>
                </div>
                <div class="timeline-item">
                    <h4>Age 18: First Episode</h4>
                    <p>Auditory hallucinations, paranoid delusions, hospitalization</p>
                </div>
                <div class="timeline-item">
                    <h4>Age 19-20: Treatment</h4>
                    <p>Started on risperidone, CBT, family therapy</p>
                </div>
                <div class="timeline-item">
                    <h4>Age 21-22: Recovery</h4>
                    <p>Returned to college part-time, minimal symptoms, good medication adherence</p>
                </div>
            </div>
            <div class="button-group">
                <button class="info-btn"onclick="showContent('james-treatment-timeline')"><i class="fas fa-chart-line"></i> Treatment Timeline</button>
                <button class="info-btn"onclick="showContent('james-clinical-notes')"><i class="fas fa-notes-medical"></i> Clinical Notes</button>
                <button class="info-btn" onclick="openLink('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930984/')">
            <i class="fas fa-book-medical"></i> Similar Cases</button>
            </div>
        </div>

        <!-- Slide 15: Case Study 2 -->
        <div class="slide">
            <div class="slide-number">15 / 20</div>
            <h1>Case Study: Treatment-Resistant Schizophrenia</h1>
            <div class="highlight-box">
                <h3>Patient Profile: "Sarah"</h3>
                <p><strong>Age:</strong> 35 years old | <strong>Gender:</strong> Female | <strong>Onset:</strong> Age 23 | <strong>Duration:</strong> 12 years</p>
            </div>
            <table>
                <thead>
                    <tr>
                        <th>Medication Trial</th>
                        <th>Duration</th>
                        <th>Response</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Risperidone</td>
                        <td>8 months</td>
                        <td>Partial response, weight gain</td>
                    </tr>
                    <tr>
                        <td>Olanzapine</td>
                        <td>6 months</td>
                        <td>Minimal improvement</td>
                    </tr>
                    <tr>
                        <td>Aripiprazole</td>
                        <td>10 months</td>
                        <td>No significant change</td>
                    </tr>
                    <tr>
                        <td>Clozapine</td>
                        <td>Ongoing (2 years)</td>
                        <td>70% symptom reduction</td>
                    </tr>
                </tbody>
            </table>
            <div class="highlight-box" style="margin-top: 20px;">
                <p><strong>Key Learning:</strong> Clozapine remains the gold standard for treatment-resistant schizophrenia, with regular blood monitoring required.</p>
            </div>
        </div>

        <!-- Slide 16: Prognosis and Outcomes -->
        <div class="slide">
            <div class="slide-number">16 / 20</div>
            <h1>Prognosis and Long-term Outcomes</h1>
            <div class="chart-container" style="max-width: 800px;">
                <canvas id="prognosisChart"></canvas>
            </div>
            <div class="two-column" style="margin-top: 40px;">
                <div>
                    <h3>Favorable Prognostic Factors:</h3>
                    <ul>
                        <li>Later age of onset</li>
                        <li>Acute onset</li>
                        <li>Good premorbid functioning</li>
                        <li>Married/strong social support</li>
                        <li>Positive symptoms predominant</li>
                        <li>Good treatment adherence</li>
                    </ul>
                </div>
                <div>
                    <h3>Poor Prognostic Factors:</h3>
                    <ul>
                        <li>Early age of onset</li>
                        <li>Insidious onset</li>
                        <li>Poor premorbid functioning</li>
                        <li>Social isolation</li>
                        <li>Negative symptoms predominant</li>
                        <li>Substance abuse</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- Slide 17: Future Directions -->
        <div class="slide">
            <div class="slide-number">17 / 20</div>
            <h1>Future Directions in Research</h1>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 30px;">
                <div class="stat-box">
                    <i class="fas fa-microscope" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Precision Medicine</h3>
                    <p>Genetic markers for treatment selection</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-robot" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Digital Therapeutics</h3>
                    <p>Apps for symptom monitoring and CBT</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-brain" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Neuromodulation</h3>
                    <p>TMS and tDCS for cognitive symptoms</p>
                </div>
                <div class="stat-box">
                    <i class="fas fa-syringe" style="font-size: 2em; color: #7C3AED;"></i>
                    <h3>Novel Medications</h3>
                    <p>Glutamate and GABA modulators</p>
                </div>
            </div>
            <div class="highlight-box" style="margin-top: 30px;">
                <h3>Emerging Areas:</h3>
                <ul>
                    <li>Immunopsychiatry - role of inflammation</li>
                    <li>Gut-brain axis research</li>
                    <li>Early detection biomarkers</li>
                    <li>Virtual reality therapy</li>
                    <li>Peer support networks</li>
                </ul>
            </div>
        </div>

        <!-- Slide 18: Key Takeaways -->
        <div class="slide">
            <div class="slide-number">18 / 20</div>
            <h1>Key Takeaways</h1>
            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 30px; margin-top: 40px;">
                <div class="highlight-box">
                    <h3>1. Complex Disorder</h3>
                    <p>Schizophrenia involves multiple brain systems and has diverse presentations</p>
                </div>
                <div class="highlight-box">
                    <h3>2. Spectrum Concept</h3>
                    <p>Recognition of various related disorders with different durations and severities</p>
                </div>
                <div class="highlight-box">
                    <h3>3. Multifactorial Etiology</h3>
                    <p>Genetic vulnerability + environmental factors = increased risk</p>
                </div>
                <div class="highlight-box">
                    <h3>4. Treatment Works</h3>
                    <p>Combination of medication and psychosocial interventions most effective</p>
                </div>
                <div class="highlight-box">
                    <h3>5. Early Intervention</h3>
                    <p>Better outcomes with prompt treatment during first episode</p>
                </div>
                <div class="highlight-box">
                    <h3>6. Hope for Recovery</h3>
                    <p>Many individuals lead fulfilling lives with proper treatment and support</p>
                </div>
            </div>
        </div>

        <!-- Slide 19: References -->
        <div class="slide">
            <div class="slide-number">19 / 20</div>
            <h1>References</h1>
            <div style="max-height: 500px; overflow-y: auto;">
                <p class="reference">1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.</p>
                <p class="reference">2. Trubetskoy, V., et al. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508.</p>
                <p class="reference">3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180
                                <p class="reference">3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180(2), 156-168.</p>
                <p class="reference">4. Howes, O. D., & Murray, R. M. (2014). Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677-1687.</p>
                <p class="reference">5. Leucht, S., et al. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia. Schizophrenia Bulletin, 43(4), 837-851.</p>
                <p class="reference">6. McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophreniaâ€”an overview. JAMA Psychiatry, 77(2), 201-210.</p>
                <p class="reference">7. Millan, M. J., et al. (2016). Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery, 15(7), 485-515.</p>
                <p class="reference">8. Owen, M. J., Sawa, A., & Mortensen, P. B. (2016). Schizophrenia. The Lancet, 388(10039), 86-97.</p>
                <p class="reference">9. Ripke, S., et al. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427.</p>
                <p class="reference">10. Stahl, S. M. (2018). Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis. CNS Spectrums, 23(3), 187-191.</p>
                <p class="reference">11. Van Os, J., & Kapur, S. (2009). Schizophrenia. The Lancet, 374(9690), 635-645.</p>
                <p class="reference">12. World Health Organization. (2022). Schizophrenia Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/schizophrenia</p>
                <p class="reference">13. Jauhar, S., et al. (2022). Cognitive-behavioural therapy for the symptoms of schizophrenia. The British Journal of Psychiatry, 220(3), 134-142.</p>
                <p class="reference">14. Kane, J. M., & Correll, C. U. (2022). Treatment-resistant schizophrenia: Definition and assessment. The Journal of Clinical Psychiatry, 83(5), MS21078COM5.</p>
                    <button class="info-btn" onclick="downloadReferences()">
    <i class="fas fa-download"></i> Download All References
</button>
            </div>
        </div>

        <!-- Slide 20: Thank You -->
<div class="slide">
    <div class="slide-number">20 / 20</div>
    <div style="text-align: center; margin-top: 150px;">
        <div class="icon-box" style="margin: 0 auto 30px; width: 100px; height: 100px; font-size: 40px;">
            <i class="fas fa-heart"></i>
        </div>
        <h1 style="font-size: 3em;">Thank You!</h1>
        <p style="font-size: 1.5em; color: #6B7280; margin: 30px 0;">Questions & Discussion</p>
        
        <div style="background: #F3F4F6; padding: 20px; border-radius: 15px; max-width: 600px; margin: 30px auto;">
            <h3 style="color: #7C3AED; margin-bottom: 15px;">Presented by: Srijan Dev</h3>
            <p style="color: #6B7280;"><i class="fas fa-phone"></i> +91 9412012157</p>
            <p style="color: #6B7280;"><i class="fas fa-envelope"></i> srijandsofficial@gmail.com</p>
        </div>
        
        <div class="button-group" style="justify-content: center;">
            <button class="info-btn" onclick="showContent('contact')">
                <i class="fas fa-envelope"></i> Contact Me
            </button>
            <button class="info-btn" onclick="downloadPresentationSummary()"><i class="fas fa-file-code"></i> Download HTML Summary</button>

            <button class="info-btn" onclick="downloadPrintableSummary()"><i class="fas fa-print"></i> Print Summary</button>
            <button class="info-btn" onclick="openLink('https://www.nimh.nih.gov/health/topics/schizophrenia')">
                <i class="fas fa-book"></i> Additional Resources
            </button>
            <button class="info-btn" onclick="downloadAllMaterials()"><i class="fas fa-download"></i> Download Complete Package</button>
        </div>
        
        <div style="margin-top: 50px;">
            <p style="color: #9CA3AF;">Psychology | 2025</p>
        </div>
    </div>
</div>

    <div class="navigation">
        <button class="nav-btn" id="prevBtn" onclick="changeSlide(-1)">
            <i class="fas fa-chevron-left"></i> Previous
        </button>
        <button class="nav-btn" id="nextBtn" onclick="changeSlide(1)">
            Next <i class="fas fa-chevron-right"></i>
        </button>
    </div>

    <script>
        let currentSlide = 0;
        const slides = document.querySelectorAll('.slide');
        const totalSlides = slides.length;
        const progressBar = document.getElementById('progressBar');

        function showSlide(n) {
            slides.forEach((slide, index) => {
                slide.classList.remove('active', 'prev');
                if (index < n) {
                    slide.classList.add('prev');
                }
            });
            
            if (n >= 0 && n < totalSlides) {
                slides[n].classList.add('active');
                currentSlide = n;
                
                // Update progress bar
                const progress = ((n + 1) / totalSlides) * 100;
                progressBar.style.width = progress + '%';
                
                // Update navigation buttons
                document.getElementById('prevBtn').disabled = n === 0;
                document.getElementById('nextBtn').disabled = n === totalSlides - 1;
                
                // Initialize charts when their slides are shown
                initializeCharts(n);
            }
        }

        function changeSlide(direction) {
            const newSlide = currentSlide + direction;
            if (newSlide >= 0 && newSlide < totalSlides) {
                showSlide(newSlide);
            }
        }

        // Keyboard navigation
        document.addEventListener('keydown', (e) => {
            if (e.key === 'ArrowLeft') changeSlide(-1);
            if (e.key === 'ArrowRight') changeSlide(1);
        });
        

        // Initialize charts
        function initializeCharts(slideNumber) {
            switch(slideNumber) {
                case 4: // Spectrum Chart
                    if (!document.getElementById('spectrumChart').chart) {
                        const ctx = document.getElementById('spectrumChart').getContext('2d');
                        document.getElementById('spectrumChart').chart = new Chart(ctx, {
                            type: 'bar',
                            data: {
                                labels: ['Schizotypal PD', 'Delusional', 'Brief Psychotic', 'Schizophreniform', 'Schizophrenia', 'Schizoaffective'],
                                datasets: [{
                                    label: 'Typical Duration (months)',
                                    data: [999, 6, 0.5, 3, 12, 999],
                                    backgroundColor: '#7C3AED',
                                    borderColor: '#6D28D9',
                                    borderWidth: 2
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: true,
                                        title: {
                                            display: true,
                                            text: 'Duration (months)'
                                        }
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 6: // Symptoms Chart
                    if (!document.getElementById('symptomsChart').chart) {
                        const ctx = document.getElementById('symptomsChart').getContext('2d');
                        document.getElementById('symptomsChart').chart = new Chart(ctx, {
                            type: 'doughnut',
                            data: {
                                labels: ['Positive Symptoms', 'Negative Symptoms', 'Cognitive Symptoms'],
                                datasets: [{
                                    data: [35, 40, 25],
                                    backgroundColor: ['#7C3AED', '#A78BFA', '#C4B5FD'],
                                    borderWidth: 0
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                plugins: {
                                    legend: {
                                        position: 'bottom'
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 8: // Genetics Chart
                    if (!document.getElementById('geneticsChart').chart) {
                        const ctx = document.getElementById('geneticsChart').getContext('2d');
                        document.getElementById('geneticsChart').chart = new Chart(ctx, {
                            type: 'bar',
                            data: {
                                labels: ['General Population', 'Sibling', 'Fraternal Twin', 'Identical Twin', 'Both Parents'],
                                datasets: [{
                                    label: 'Risk of Schizophrenia (%)',
                                    data: [1, 9, 17, 48, 46],
                                    backgroundColor: '#7C3AED',
                                    borderColor: '#6D28D9',
                                    borderWidth: 2
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: true,
                                        max: 50,
                                        title: {
                                            display: true,
                                            text: 'Risk Percentage'
                                        }
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 10: // Treatment Chart
                    if (!document.getElementById('treatmentChart').chart) {
                        const ctx = document.getElementById('treatmentChart').getContext('2d');
                        document.getElementById('treatmentChart').chart = new Chart(ctx, {
                            type: 'line',
                            data: {
                                labels: ['Baseline', '2 weeks', '4 weeks', '8 weeks', '12 weeks', '6 months'],
                                datasets: [{
                                    label: 'Medication Only',
                                    data: [100, 85, 70, 60, 50, 45],
                                    borderColor: '#A78BFA',
                                    backgroundColor: 'rgba(167, 139, 250, 0.1)',
                                    tension: 0.4
                                }, {
                                    label: 'Combined Treatment',
                                    data: [100, 80, 60, 45, 35, 30],
                                    borderColor: '#7C3AED',
                                    backgroundColor: 'rgba(124, 58, 237, 0.1)',
                                    tension: 0.4
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: true,
                                        max: 100,
                                        title: {
                                            display: true,
                                            text: 'Symptom Severity (%)'
                                        }
                                    }
                                },
                                plugins: {
                                    title: {
                                        display: true,
                                        text: 'Treatment Response Over Time'
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 11: // Research Chart 1
                    if (!document.getElementById('researchChart1').chart) {
                        const ctx = document.getElementById('researchChart1').getContext('2d');
                        document.getElementById('researchChart1').chart = new Chart(ctx, {
                            type: 'radar',
                            data: {
                                labels: ['Synaptic', 'Neuronal', 'Immune', 'Metabolic', 'Developmental'],
                                datasets: [{
                                    label: 'Gene Involvement',
                                    data: [85, 70, 45, 30, 60],
                                    borderColor: '#7C3AED',
                                    backgroundColor: 'rgba(124, 58, 237, 0.2)',
                                    pointBackgroundColor: '#7C3AED'
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    r: {
                                        beginAtZero: true,
                                        max: 100
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 12: // Brain Chart
                    if (!document.getElementById('brainChart').chart) {
                        const ctx = document.getElementById('brainChart').getContext('2d');
                        document.getElementById('brainChart').chart = new Chart(ctx, {
                            type: 'line',
                            data: {
                                labels: ['Baseline', 'Year 2', 'Year 4', 'Year 6', 'Year 8', 'Year 10'],
                                datasets: [{
                                    label: 'Patients',
                                    data: [100, 98, 95, 93, 91, 89],
                                    borderColor: '#DC2626',
                                    backgroundColor: 'rgba(220, 38, 38, 0.1)',
                                    tension: 0.4
                                }, {
                                    label: 'Controls',
                                    data: [100, 99.5, 99, 98.5, 98, 97.5],
                                    borderColor: '#10B981',
                                    backgroundColor: 'rgba(16, 185, 129, 0.1)',
                                    tension: 0.4
                                }]
                            },
                            options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                scales: {
                                    y: {
                                        beginAtZero: false,
                                        min: 85,
                                        max: 101,
                                        title: {
                                            display: true,
                                            text: 'Gray Matter Volume (%)'
                                        }
                                    }
                                },
                                plugins: {
                                    title: {
                                        display: true,
                                        text: 'Longitudinal Brain Volume Changes'
                                    }
                                }
                            }
                        });
                    }
                    break;
                    
                case 15: // Prognosis Chart
                    if (!document.getElementById('prognosisChart').chart) {
                        const ctx = document.getElementById('prognosisChart').getContext('2d');
                        document.getElementById('prognosisChart').chart = new Chart(ctx, {
                            type: 'pie',
                            data: {
                                labels: ['Good Recovery (25%)', 'Moderate Improvement (35%)', 'Limited Improvement (25%)', 'Poor Outcome (15%)'],
                                datasets: [{
                                    data: [25, 35, 25, 15],
                                    backgroundColor: ['#10B981', '#3B82F6', '#F59E0B', '#EF4444'],
                                    borderWidth: 0
                                }]
                            },
                                                        options: {
                                responsive: true,
                                maintainAspectRatio: false,
                                plugins: {
                                    title: {
                                        display: true,
                                        text: 'Long-term Outcomes in Schizophrenia',
                                        font: {
                                            size: 16
                                        }
                                    },
                                    legend: {
                                        position: 'bottom'
                                    }
                                }
                            }
                        });
                    }
                    break;
            }
        }

        // Initialize first slide
        showSlide(0);

        // Add smooth scrolling for slides with overflow
        document.querySelectorAll('.slide').forEach(slide => {
            slide.addEventListener('wheel', (e) => {
                if (slide.scrollHeight > slide.clientHeight) {
                    e.stopPropagation();
                }
            });
        });

        // Add touch support for mobile devices
        let touchStartX = 0;
        let touchEndX = 0;

        document.addEventListener('touchstart', (e) => {
            touchStartX = e.changedTouches[0].screenX;
        });

        document.addEventListener('touchend', (e) => {
            touchEndX = e.changedTouches[0].screenX;
            handleSwipe();
        });

        function handleSwipe() {
            if (touchEndX < touchStartX - 50) {
                changeSlide(1); // Swipe left, go to next slide
            }
            if (touchEndX > touchStartX + 50) {
                changeSlide(-1); // Swipe right, go to previous slide
            }
        }

        // Add fullscreen support
        document.addEventListener('keydown', (e) => {
            if (e.key === 'f' || e.key === 'F') {
                if (!document.fullscreenElement) {
                    document.documentElement.requestFullscreen();
                } else {
                    document.exitFullscreen();
                }
            }
        });

        // Add loading animation for charts
        Chart.defaults.animation.duration = 1000;
        Chart.defaults.animation.easing = 'easeInOutQuart';

        // Preload all slides content
        window.addEventListener('load', () => {
            slides.forEach((slide, index) => {
                slide.style.display = 'block';
                setTimeout(() => {
                    if (index !== 0) {
                        slide.style.display = '';
                    }
                }, 100);
            });
        });

        // Add print support
        window.addEventListener('beforeprint', () => {
            slides.forEach(slide => {
                slide.classList.add('active');
                slide.style.position = 'relative';
                slide.style.opacity = '1';
                slide.style.transform = 'none';
                slide.style.pageBreakAfter = 'always';
            });
        });

        window.addEventListener('afterprint', () => {
            showSlide(currentSlide);
            slides.forEach(slide => {
                slide.style.position = '';
                slide.style.pageBreakAfter = '';
            });
        });
    // Button click handlers
function openLink(url) {
    window.open(url, '_blank');
}

function showContent(contentId) {
    const modal = document.getElementById('modal');
    const modalTitle = document.getElementById('modalTitle');
    const modalBody = document.getElementById('modalBody');
    
    const content = buttonContentData[contentId];
    if (content) {
        modalTitle.textContent = content.title;
        modalBody.innerHTML = content.body;
        modal.style.display = 'block';
    }
}
 // Function to show modal content
    function showContent(contentId) {
        const modal = document.getElementById('modal');
        const modalTitle = document.getElementById('modalTitle');
        const modalBody = document.getElementById('modalBody');
        
        const content = buttonContentData[contentId];
        if (content) {
            modalTitle.textContent = content.title;
            modalBody.innerHTML = content.body;
            modal.style.display = 'block';
        } else {
            console.error('Content not found for:', contentId);
        }
    }

    // Function to open external links
    function openLink(url) {
        window.open(url, '_blank');
    }

    // Modal close functionality
    document.addEventListener('DOMContentLoaded', function() {
        const modal = document.getElementById('modal');
        const closeBtn = document.getElementsByClassName('close')[0];
        
        if (closeBtn) {
            closeBtn.onclick = function() {
                modal.style.display = 'none';
            }
        }
        
        // Close modal when clicking outside
        window.onclick = function(event) {
            if (event.target == modal) {
                modal.style.display = 'none';
            }
        }
    });
// ADD ALL OF THIS:
    
    // Button content data object
    // (Removed duplicate declaration to avoid redeclaration error)
// Button content data

const buttonContentData = {
        'dsm5-checklist': {
            title: 'DSM-5 Diagnostic Checklist for Schizophrenia',
            body: `
                <div class="modal-list">
                    <h3>Criterion A: Two or more of the following for â‰¥1 month:</h3>
                    <div style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin: 15px 0;">
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>1. Delusions</strong> - Fixed false beliefs
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>2. Hallucinations</strong> - Perceptual experiences without stimuli
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>3. Disorganized speech</strong> - Derailment or incoherence
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>4. Disorganized/catatonic behavior</strong>
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>5. Negative symptoms</strong> - Diminished emotional expression
                        </label>
                    </div>
                    
                    <h3 style="margin-top: 20px;">Additional Criteria:</h3>
                    <div style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin: 15px 0;">
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>B:</strong> Significant functional decline in work, relationships, or self-care
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>C:</strong> Continuous signs persist for at least 6 months
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>D:</strong> Schizoaffective and mood disorders ruled out
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>E:</strong> Not due to substance use or medical condition
                        </label>
                        <label style="display: block; margin: 10px 0;">
                            <input type="checkbox"> <strong>F:</strong> If autism history, prominent hallucinations/delusions present
                        </label>
                    </div>
                    
                    <div style="margin-top: 20px; text-align: center;">
                        <button class="info-btn" onclick="window.print()">
                            <i class="fas fa-print"></i> Print Checklist
                        </button>
                        <button class="info-btn" onclick="openLink('https://www.psychiatry.org/psychiatrists/practice/dsm')" style="margin-left: 10px;">
                            <i class="fas fa-external-link-alt"></i> Official DSM-5 Website
                        </button>
                    </div>
                </div>
            `
        },
    'panss-scale': {
            title: 'PANSS - Positive and Negative Syndrome Scale',
            body: `
                <div class="resource-card">
                    <h4>About PANSS</h4>
                    <p>The PANSS is a 30-item rating scale for measuring symptom severity in schizophrenia.</p>
                    
                    <h4 style="margin-top: 20px;">Scale Components:</h4>
                    <ul>
                        <li><strong>Positive Scale (7 items):</strong> P1-P7</li>
                        <li><strong>Negative Scale (7 items):</strong> N1-N7</li>
                        <li><strong>General Psychopathology (16 items):</strong> G1-G16</li>
                    </ul>
                    
                    <h4 style="margin-top: 20px;">Scoring:</h4>
                    <p>Each item rated 1-7 (1 = absent, 7 = extreme)</p>
                    
                    <div style="margin-top: 20px;">
                        <button class="info-btn" onclick="openLink('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219910/')">
                            <i class="fas fa-file-pdf"></i> PANSS Manual
                        </button>
                    </div>
                </div>
            `
        },
        'james-treatment-timeline': {
        title: 'James - Detailed Treatment Timeline',
        body: `
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 1: Prodromal Period (Age 16-17)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Duration:</strong> 18 months</li>
                    <li style="margin: 8px 0;"><strong>Symptoms:</strong> Social anxiety, odd beliefs, concentration difficulties</li>
                    <li style="margin: 8px 0;"><strong>Interventions:</strong> School counseling, family meetings</li>
                    <li style="margin: 8px 0;"><strong>Outcome:</strong> Limited improvement, symptoms progressed</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 2: First Episode (Age 18)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Duration:</strong> 3 months acute phase</li>
                    <li style="margin: 8px 0;"><strong>Symptoms:</strong> Command hallucinations, paranoid delusions, disorganized thinking</li>
                    <li style="margin: 8px 0;"><strong>Interventions:</strong> 
                        <ul style="margin-left: 20px; margin-top: 5px;">
                            <li>Hospitalization (21 days)</li>
                            <li>Risperidone 2mg titrated to 4mg/day</li>
                            <li>Lorazepam PRN for agitation</li>
                        </ul>
                    </li>
                    <li style="margin: 8px 0;"><strong>Outcome:</strong> 60% symptom reduction, able to return home</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 3: Stabilization (Age 19-20)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Medications:</strong> Risperidone 3mg/day (maintenance dose)</li>
                    <li style="margin: 8px 0;"><strong>Therapy:</strong> 
                        <ul style="margin-left: 20px; margin-top: 5px;">
                            <li>Weekly CBT for psychosis (CBTp)</li>
                            <li>Monthly family therapy</li>
                            <li>Bi-weekly medication management</li>
                        </ul>
                    </li>
                    <li style="margin: 8px 0;"><strong>Support Services:</strong> Case management, vocational rehabilitation</li>
                    <li style="margin: 8px 0;"><strong>Outcome:</strong> Achieved clinical remission, enrolled in online courses</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Phase 4: Recovery & Maintenance (Age 21-22)</h4>
                <ul style="list-style: none; padding: 0;">
                    <li style="margin: 8px 0;"><strong>Current Status:</strong> Part-time college student (12 credits)</li>
                    <li style="margin: 8px 0;"><strong>Medications:</strong> Risperidone 2mg/day (reduced dose)</li>
                    <li style="margin: 8px 0;"><strong>Ongoing Support:</strong> 
                        <ul style="margin-left: 20px; margin-top: 5px;">
                            <li>Monthly psychiatry appointments</li>
                            <li>Peer support group (weekly)</li>
                            <li>Academic accommodations</li>
                        </ul>
                    </li>
                    <li style="margin: 8px 0;"><strong>Functioning:</strong> Living independently with roommate, part-time job at library</li>
                </ul>
            </div>
        `
    },
    'james-clinical-notes': {
        title: 'James - Clinical Notes Summary',
        body: `
            <div style="background: #FEF3C7; padding: 20px; border-radius: 10px; margin-bottom: 20px;">
                <h4 style="color: #92400E; margin-bottom: 15px;">Initial Presentation (Age 18)</h4>
                <p><strong>Chief Complaint:</strong> "People are watching me and controlling my thoughts through the WiFi"</p>
                <p><strong>Mental Status Exam:</strong></p>
                <ul style="margin-left: 20px;">
                    <li>Appearance: Disheveled, poor hygiene</li>
                    <li>Behavior: Guarded, covering ears intermittently</li>
                    <li>Speech: Tangential, increased latency</li>
                    <li>Mood: "Scared"</li>
                    <li>Affect: Restricted, fearful</li>
                    <li>Thought Process: Disorganized</li>
                    <li>Thought Content: Paranoid delusions, ideas of reference</li>
                    <li>Perceptions: Auditory hallucinations (commanding)</li>
                    <li>Insight/Judgment: Poor/Impaired</li>
                </ul>
            </div>
            
            <h4 style="color: #7C3AED; margin: 20px 0;">Treatment Progress - Assessment Scores</h4>
            <table style="width: 100%; border-collapse: collapse; background: white; border-radius: 10px; overflow: hidden; box-shadow: 0 2px 10px rgba(0,0,0,0.1);">
                <thead>
                    <tr style="background: #7C3AED; color: white;">
                        <th style="padding: 15px; text-align: left;">Assessment Tool</th>
                        <th style="padding: 15px; text-align: center;">Baseline</th>
                        <th style="padding: 15px; text-align: center;">3 Months</th>
                        <th style="padding: 15px; text-align: center;">6 Months</th>
                        <th style="padding: 15px; text-align: center;">Current (2 years)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr style="background: #F9FAFB;">
                        <td style="padding: 15px;">PANSS Total</td>
                        <td style="padding: 15px; text-align: center;">95</td>
                        <td style="padding: 15px; text-align: center;">72</td>
                        <td style="padding: 15px; text-align: center;">62</td>
                        <td style="padding: 15px; text-align: center;">48</td>
                    </tr>
                    <tr>
                        <td style="padding: 15px;">PANSS Positive</td>
                        <td style="padding: 15px; text-align: center;">28</td>
                        <td style="padding: 15px; text-align: center;">18</td>
                        <td style="padding: 15px; text-align: center;">14</td>
                        <td style="padding: 15px; text-align: center;">10</td>
                    </tr>
                    <tr style="background: #F9FAFB;">
                        <td style="padding: 15px;">PANSS Negative</td>
                        <td style="padding: 15px; text-align: center;">24</td>
                        <td style="padding: 15px; text-align: center;">20</td>
                        <td style="padding: 15px; text-align: center;">18</td>
                        <td style="padding: 15px; text-align: center;">15</td>
                    </tr>
                    <tr>
                        <td style="padding: 15px;">GAF Score</td>
                        <td style="padding: 15px; text-align: center;">25</td>
                        <td style="padding: 15px; text-align: center;">45</td>
                        <td style="padding: 15px; text-align: center;">55</td>
                        <td style="padding: 15px; text-align: center;">72</td>
                    </tr>
                    <tr style="background: #F9FAFB;">
                        <td style="padding: 15px;">CGI-Severity</td>
                        <td style="padding: 15px; text-align: center;">6 (Severely ill)</td>
                        <td style="padding: 15px; text-align: center;">4 (Moderately ill)</td>
                        <td style="padding: 15px; text-align: center;">3 (Mildly ill)</td>
                        <td style="padding: 15px; text-align: center;">2 (Borderline ill)</td>
                    </tr>
                </tbody>
            </table>
            
            <div class="resource-card" style="background: #F3F4F6; padding: 20px; border-radius: 10px; margin-top: 20px;">
                <h4 style="color: #7C3AED; margin-bottom: 15px;">Clinical Observations & Strengths:</h4>
                <ul>
                    <li>Excellent medication adherence after initial psychoeducation</li>
                    <li>Strong family support system (parents very involved)</li>
                    <li>Good premorbid functioning (B+ student before onset)</li>
                    <li>Developed good insight over treatment course</li>
                    <li>No comorbid substance use</li>
                    <li>Highly motivated for recovery</li>
                    <li>Responsive to CBT interventions</li>
                </ul>
            </div>
            
            <div class="resource-card" style="background: #FEE2E2; padding: 20px; border-radius: 10px; margin-top: 20px;">
                <h4 style="color: #DC2626; margin-bottom: 15px;">Risk Factors & Monitoring:</h4>
                <ul>
                    <li><strong>Suicide Risk:</strong> Currently Low (no SI/HI, good future planning)</li>
                    <li><strong>Violence Risk:</strong> Low (no history of aggression)</li>
                    <li><strong>Relapse Indicators:</strong> Sleep disturbance, social withdrawal, missing appointments</li>
                    <li><strong>Stressors to Monitor:</strong> Academic pressure, social relationships</li>
                </ul>
            </div>
        `
    },
    'contact': {
        title: 'Contact Information',
        body: `
            <div class="resource-card" style="background: linear-gradient(135deg, #EDE9FE 0%, #DDD6FE 100%); padding: 30px; border-radius: 15px; text-align: center;">
                <div class="icon-box" style="margin: 0 auto 20px; width: 80px; height: 80px; background: white; display: flex; align-items: center; justify-content: center; border-radius: 20px; box-shadow: 0 4px 15px rgba(124, 58, 237, 0.2);">
                    <i class="fas fa-user-graduate" style="font-size: 40px; color: #7C3AED;"></i>
                </div>
                <h3 style="color: #5B21B6; margin-bottom: 20px;">Srijan Dev</h3>
                <p style="color: #6B7280; margin-bottom: 30px;">Psychology Student | Schizophrenia Research Presentation</p>
                
                <div style="text-align: left; background: white; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h4 style="color: #7C3AED; margin-bottom: 15px;"><i class="fas fa-address-card"></i> Get in Touch</h4>
                    
                    <div style="margin: 15px 0; display: flex; align-items: center; gap: 15px;">
                        <i class="fas fa-phone" style="color: #7C3AED; font-size: 20px; width: 30px;"></i>
                        <div>
                            <p style="margin: 0; color: #4B5563; font-weight: 600;">Phone</p>
                            <a href="tel:+919412012157" style="color: #7C3AED; text-decoration: none; font-size: 18px;">+91 9412012157</a>
                        </div>
                    </div>
                    
                    <div style="margin: 15px 0; display: flex; align-items: center; gap: 15px;">
                        <i class="fas fa-envelope" style="color: #7C3AED; font-size: 20px; width: 30px;"></i>
                        <div>
                            <p style="margin: 0; color: #4B5563; font-weight: 600;">Primary Email</p>
                            <a href="mailto:srijandsofficial@gmail.com" style="color: #7C3AED; text-decoration: none;">srijandsofficial@gmail.com</a>
                        </div>
                    </div>
                    
                    <div style="margin: 15px 0; display: flex; align-items: center; gap: 15px;">
                        <i class="fas fa-envelope-open" style="color: #7C3AED; font-size: 20px; width: 30px;"></i>
                        <div>
                            <p style="margin: 0; color: #4B5563; font-weight: 600;">Alternative Email</p>
                            <a href="mailto:ssrijandev@gmail.com" style="color: #7C3AED; text-decoration: none;">ssrijandev@gmail.com</a>
                        </div>
                    </div>
                </div>
                
                <div style="background: #F3F4F6; padding: 20px; border-radius: 15px; margin-bottom: 20px;">
                    <h4 style="color: #7C3AED; margin-bottom: 10px;">Quick Actions</h4>
                    <div class="button-group" style="justify-content: center; margin-top: 15px;">
                        <button class="info-btn" onclick="window.location.href='tel:+919412012157'" style="background: #10B981;">
                            <i class="fas fa-phone"></i> Call Now
                        </button>
                        <button class="info-btn" onclick="window.location.href='mailto:srijandsofficial@gmail.com'">
                            <i class="fas fa-envelope"></i> Send Email
                        </button>
                        <button class="info-btn" onclick="copyContact()" style="background: #3B82F6;">
                            <i class="fas fa-copy"></i> Copy Contact
                        </button>
                    </div>
                </div>
                
                <div style="background: #FEF3C7; padding: 15px; border-radius: 10px; color: #92400E;">
                    <p style="margin: 0;"><i class="fas fa-clock"></i> Available for academic discussions and questions about this presentation</p>
                </div>
            </div>
            
            <div style="text-align: center; margin-top: 20px; color: #6B7280;">
                <p><i class="fas fa-university"></i> Psychology Department | 2024</p>
            </div>
        `
    },
    'clinical-assessment-tools': {
        title: 'Clinical Assessment Tools for Schizophrenia',
        body: `
            <div style="max-height: 600px; overflow-y: auto;">
                <!-- PANSS Scale -->
                <div class="resource-card" style="background: #EDE9FE; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #5B21B6; margin-bottom: 15px;">
                        <i class="fas fa-clipboard-check"></i> PANSS - Positive and Negative Syndrome Scale
                    </h3>
                    <p style="color: #6B7280; margin-bottom: 15px;">30-item rating scale (7-point severity scale: 1=absent to 7=extreme)</p>
                    
                    <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 15px; margin-top: 20px;">
                        <div style="background: white; padding: 15px; border-radius: 10px;">
                            <h4 style="color: #7C3AED; font-size: 14px;">Positive Scale (7 items)</h4>
                            <ul style="font-size: 13px; color: #4B5563; margin: 10px 0; padding-left: 20px;">
                                <li>P1: Delusions</li>
                                <li>P2: Conceptual disorganization</li>
                                <li>P3: Hallucinations</li>
                                <li>P4: Hyperactivity</li>
                                <li>P5: Grandiosity</li>
                                <li>P6: Suspiciousness</li>
                                <li>P7: Hostility</li>
                            </ul>
                        </div>
                        
                        <div style="background: white; padding: 15px; border-radius: 10px;">
                            <h4 style="color: #7C3AED; font-size: 14px;">Negative Scale (7 items)</h4>
                            <ul style="font-size: 13px; color: #4B5563; margin: 10px 0; padding-left: 20px;">
                                <li>N1: Blunted affect</li>
                                <li>N2: Emotional withdrawal</li>
                                <li>N3: Poor rapport</li>
                                <li>N4: Passive withdrawal</li>
                                <li>N5: Abstract thinking</li>
                                <li>N6: Spontaneity</li>
                                <li>N7: Stereotyped thinking</li>
                            </ul>
                        </div>
                        
                        <div style="background: white; padding: 15px; border-radius: 10px;">
                            <h4 style="color: #7C3AED; font-size: 14px;">General (16 items)</h4>
                            <p style="font-size: 13px; color: #4B5563;">Including anxiety, depression, cognitive symptoms, etc.</p>
                            <div style="margin-top: 10px;">
                                <span style="background: #7C3AED; color: white; padding: 5px 10px; border-radius: 15px; font-size: 12px;">
                                    Total Score: 30-210
                                </span>
                            </div>
                        </div>
                    </div>
                    
                    <button class="info-btn" onclick="openLink('https://www.psychiatrictimes.com/view/how-use-panss')" style="margin-top: 15px;">
                        <i class="fas fa-external-link-alt"></i> PANSS Training Guide
                    </button>
                </div>
                
                <!-- BPRS Scale -->
                <div class="resource-card" style="background: #DBEAFE; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #1E40AF; margin-bottom: 15px;">
                        <i class="fas fa-chart-line"></i> BPRS - Brief Psychiatric Rating Scale
                    </h3>
                    <p style="color: #6B7280;">18-item scale, each rated 1-7 based on severity</p>
                    
                    <div style="background: white; padding: 20px; border-radius: 10px; margin-top: 15px;">
                        <h4 style="color: #3B82F6; font-size: 16px; margin-bottom: 10px;">Key Domains Assessed:</h4>
                        <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 15px;">
                            <div>
                                <h5 style="color: #1E40AF; font-size: 14px;">Psychotic Symptoms</h5>
                                <ul style="font-size: 13px; color: #4B5563; padding-left: 20px;">
                                    <li>Hallucinations</li>
                                    <li>Unusual thought content</li>
                                    <li>Bizarre behavior</li>
                                    <li>Disorientation</li>
                                </ul>
                            </div>
                            <div>
                                <h5 style="color: #1E40AF; font-size: 14px;">Mood & Affect</h5>
                                <ul style="font-size: 13px; color: #4B5563; padding-left: 20px;">
                                    <li>Anxiety</li>
                                    <li>Depression</li>
                                    <li>Suicidality</li>
                                    <li>Elevated mood</li>
                                </ul>
                            </div>
                        </div>
                    </div>
                </div>
                
                <!-- GAF Scale -->
                <div class="resource-card" style="background: #D1FAE5; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #065F46; margin-bottom: 15px;">
                        <i class="fas fa-tachometer-alt"></i> GAF - Global Assessment of Functioning
                    </h3>
                    <p style="color: #6B7280;">Scale from 0-100 measuring overall functioning</p>
                    
                    <table style="width: 100%; margin-top: 15px; background: white; border-radius: 10px; overflow: hidden;">
                        <tr style="background: #10B981; color: white;">
                            <th style="padding: 10px;">Score Range</th>
                            <th style="padding: 10px;">Functioning Level</th>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">91-100</td>
                            <td style="padding: 10px;">Superior functioning</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">81-90</td>
                            <td style="padding: 10px;">Absent or minimal symptoms</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">71-80</td>
                            <td style="padding: 10px;">Transient symptoms</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">61-70</td>
                            <td style="padding: 10px;">Mild symptoms</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">51-60</td>
                            <td style="padding: 10px;">Moderate symptoms</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">41-50</td>
                            <td style="padding: 10px;">Serious symptoms</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">31-40</td>
                            <td style="padding: 10px;">Major impairment</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">21-30</td>
                            <td style="padding: 10px;">Unable to function</td>
                        </tr>
                        <tr style="background: #F3F4F6;">
                            <td style="padding: 10px; text-align: center;">11-20</td>
                            <td style="padding: 10px;">Needs constant supervision</td>
                        </tr>
                        <tr>
                            <td style="padding: 10px; text-align: center;">1-10</td>
                            <td style="padding: 10px;">Persistent danger</td>
                        </tr>
                    </table>
                </div>
                
                <!-- CGI Scale -->
                <div class="resource-card" style="background: #FEF3C7; padding: 25px; border-radius: 15px; margin-bottom: 20px;">
                    <h3 style="color: #92400E; margin-bottom: 15px;">
                        <i class="fas fa-user-md"></i> CGI - Clinical Global Impression
                    </h3>
                    <p style="color: #6B7280;">Brief assessment of overall clinical status</p>
                    
                    <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 20px; margin-top: 20px;">
                        <div style="background: white; padding: 20px; border-radius: 10px;">
                            <h4 style="color: #D97706; font-size: 16px;">CGI-S (Severity)</h4>
                            <ol style="font-size: 14px; color: #4B5563; padding-left: 20px;">
                                <li>Normal, not ill</li>
                                <li>Borderline ill</li>
                                <li>Mildly ill</li>
                                <li>Moderately ill</li>
                                <li>Markedly ill</li>
                                <li>Severely ill</li>
                                <li>Extremely ill</li>
                            </ol>
                        </div>
                        
                        <div style="background: white; padding: 20px; border-radius: 10px;">
                            <h4 style="color: #D97706; font-size: 16px;">CGI-I (Improvement)</h4>
                            <ol style="font-size: 14px; color: #4B5563; padding-left: 20px;">
                                <li>Very much improved</li>
                                <li>Much improved</li>
                                <li>Minimally improved</li>
                                <li>No change</li>
                                <li>Minimally worse</li>
                                <li>Much worse</li>
                                <li>Very much worse</li>
                            </ol>
                        </div>
                    </div>
                </div>
                
                <!-- Quick Assessment Checklist -->
                <div class="resource-card" style="background: #F3F4F6; padding: 25px; border-radius: 15px;">
                    <h3 style="color: #4B5563; margin-bottom: 15px;">
                        <i class="fas fa-tasks"></i> Quick Clinical Assessment Checklist
                    </h3>
                    
                    <div style="background: white; padding: 20px; border-radius: 10px;">
                        <h4 style="color: #7C3AED; margin-bottom: 15px;">Mental Status Examination Components:</h4>
                        <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 10px;">
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Appearance & Behavior
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Speech patterns
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Mood & Affect
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Thought Process
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Thought Content
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Perceptual Disturbances
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Cognition
                            </label>
                            <label style="display: flex; align-items: center; gap: 10px;">
                                <input type="checkbox"> Insight & Judgment
                            </label>
                        </div>
                    </div>
                    
                    <div class="button-group" style="margin-top: 20px;">
                        <button class="info-btn" onclick="window.print()">
                            <i class="fas fa-print"></i> Print Assessment Forms
                        </button>
                        <button class="info-btn" onclick="downloadAssessmentPack()">
                            <i class="fas fa-download"></i> Download All Tools
                        </button>
                        <button class="info-btn" onclick="openLink('https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures')">
                            <i class="fas fa-book-medical"></i> More Resources
                        </button>
                    </div>
                </div>
            </div>
        `
    },
        'learn-history': {
        title: 'Historical Resources',
        body: `
            <div class="resource-card">
                <h4>Recommended Reading:</h4>
                <ul>
                    <li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181977/" target="_blank">
                        History of Schizophrenia - NIH Article</a></li>
                    <li><a href="https://pubmed.ncbi.nlm.nih.gov/21305003/" target="_blank">
                        Evolution of the Schizophrenia Concept</a></li>
                </ul>
            </div>
        `
    },
    
    'contact': {
        title: 'Contact Information',
        body: `
            <div class="resource-card">
                <h4>Get in Touch:</h4>
                <p><i class="fas fa-envelope"></i> srijandsofficial@gmail.com/ssrijandev@gmail.com</p>
                <p><i class="fas fa-phone"></i> +91 9412012157</p>
                <p><i class="fas fa-globe"></i> SUNY</p>
            </div>
        `
    }
};

function downloadSlides() {
    // Create a simple download
    alert('Slides download feature would be implemented here. In a real application, this would generate a PDF.');
    // In real implementation: window.open('/path/to/slides.pdf', '_blank');
} 
// Function to copy contact information to clipboard
function copyContact() {
    const contactInfo = `
Srijan Dev
Phone: +91 9412012157
Email: srijandsofficial@gmail.com
Alt Email: ssrijandev@gmail.com
    `;
    
    // Create a temporary textarea element
    const textarea = document.createElement('textarea');
    textarea.value = contactInfo.trim();
    textarea.style.position = 'fixed';
    textarea.style.left = '-9999px';
    document.body.appendChild(textarea);
    
    // Select and copy the text
    textarea.select();
    document.execCommand('copy');
    document.body.removeChild(textarea);
    
    // Show confirmation
    alert('Contact information copied to clipboard!');
}

// Update the existing buttonContentData to include this contact info
if (typeof buttonContentData !== 'undefined') {
    buttonContentData['contact'] = contactContent['contact'];
} else {
    // If buttonContentData doesn't exist, create it
    window.buttonContentData = contactContent;
}

// Also update the last slide (Thank You slide) to include your name
document.addEventListener('DOMContentLoaded', function() {
    // Find the thank you slide and update it
    const slides = document.querySelectorAll('.slide');
    const lastSlide = slides[slides.length - 1];
    
    if (lastSlide) {
        const contactInfo = lastSlide.querySelector('p[style*="color: #9CA3AF"]');
        if (contactInfo) {
            contactInfo.innerHTML = 'Presented by: Srijan Dev | Psychology | 2025';
        }
    }
});

// Add footer with contact info to all slides (optional)
function addContactFooter() {
    const slides = document.querySelectorAll('.slide');
    slides.forEach((slide, index) => {
        // Skip the first and last slides
        if (index > 0 && index < slides.length - 1) {
            const footer = document.createElement('div');
            footer.style.cssText = `
                position: absolute;
                bottom: 20px;
                left: 30px;
                font-size: 12px;
                color: #9CA3AF;
            `;
            footer.innerHTML = '<i class="fas fa-user"></i> Srijan Dev | <i class="fas fa-envelope"></i> srijandsofficial@gmail.com';
            slide.appendChild(footer);
        }
    });
}

// Call this function if you want to add footer to all slides
// addContactFooter();

// Console message for debugging
console.log('Contact script loaded successfully!');
console.log('Contact: Srijan Dev');
console.log('Phone: +91 9412012157');
console.log('Email: srijandsofficial@gmail.com');
// Function to download assessment pack
function downloadAssessmentPack() {
    alert('Clinical Assessment Tools Pack\n\nThis would download:\n- PANSS Scale Form\n- BPRS Rating Form\n- GAF Scale Guide\n- CGI Scale Forms\n- MSE Template\n\nIn production, this would download a ZIP file with all assessment tools.');
}

// Add this to your existing buttonContentData
if (typeof buttonContentData !== 'undefined') {
    Object.assign(buttonContentData, clinicalAssessmentContent);
} else {
    window.buttonContentData = clinicalAssessmentContent;
}
// Complete Download Script for All Presentation Resources

// Main download function
function downloadFile(filename, content, type = 'text/plain') {
    const blob = new Blob([content], { type: type });
    const url = window.URL.createObjectURL(blob);
    const a = document.createElement('a');
    a.href = url;
    a.download = filename;
    document.body.appendChild(a);
    a.click();
    window.URL.revokeObjectURL(url);
    document.body.removeChild(a);
}

// Download presentation slides as HTML
function downloadPresentationSummary() {
    const summaryHTML = `
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Schizophrenia Spectrum Disorders - Complete Summary</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Arial', sans-serif;
            line-height: 1.6;
            color: #333;
            background-color: #f5f5f5;
            padding: 20px;
        }
        
        .container {
            max-width: 1000px;
            margin: 0 auto;
            background: white;
            padding: 40px;
            border-radius: 10px;
            box-shadow: 0 0 20px rgba(0,0,0,0.1);
        }
        
        h1 {
            color: #5B21B6;
            border-bottom: 3px solid #7C3AED;
            padding-bottom: 15px;
            margin-bottom: 30px;
            font-size: 2.5em;
        }
        
        h2 {
            color: #6D28D9;
            margin-top: 40px;
            margin-bottom: 20px;
            font-size: 1.8em;
            border-left: 4px solid #7C3AED;
            padding-left: 15px;
        }
        
        h3 {
            color: #7C3AED;
            margin-top: 25px;
            margin-bottom: 15px;
            font-size: 1.4em;
        }
        
        h4 {
            color: #8B5CF6;
            margin-top: 20px;
            margin-bottom: 10px;
            font-size: 1.2em;
        }
        
        p {
            margin-bottom: 15px;
            text-align: justify;
        }
        
        ul, ol {
            margin-left: 30px;
            margin-bottom: 20px;
        }
        
        li {
            margin-bottom: 8px;
        }
        
        .highlight {
            background-color: #FEF3C7;
            padding: 15px;
            border-radius: 8px;
            margin: 20px 0;
            border-left: 4px solid #F59E0B;
        }
        
        .info-box {
            background-color: #EDE9FE;
            padding: 20px;
            border-radius: 8px;
            margin: 20px 0;
            border-left: 4px solid #7C3AED;
        }
        
        .warning-box {
            background-color: #FEE2E2;
            padding: 20px;
            border-radius: 8px;
            margin: 20px 0;
            border-left: 4px solid #EF4444;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            background: white;
            box-shadow: 0 2px 5px rgba(0,0,0,0.1);
        }
        
        th {
            background-color: #7C3AED;
            color: white;
            padding: 12px;
            text-align: left;
        }
        
        td {
            padding: 12px;
            border-bottom: 1px solid #e0e0e0;
        }
        
        tr:nth-child(even) {
            background-color: #f8f8f8;
        }
        
        .contact-info {
            background-color: #F3F4F6;
            padding: 20px;
            border-radius: 8px;
            margin-top: 40px;
            text-align: center;
        }
        
        .toc {
            background-color: #F9FAFB;
            padding: 25px;
            border-radius: 8px;
            margin-bottom: 40px;
        }
        
        .toc h3 {
            margin-bottom: 20px;
        }
        
        .toc ul {
            list-style-type: none;
            margin-left: 0;
        }
        
        .toc ul li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }
        
        .toc ul li:before {
            content: "â–¸";
            position: absolute;
            left: 0;
            color: #7C3AED;
        }
        
        .page-break {
            page-break-after: always;
        }
        
        @media print {
            body {
                background: white;
                padding: 0;
            }
            .container {
                box-shadow: none;
                padding: 20px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Schizophrenia Spectrum Disorders</h1>
        <p style="text-align: center; font-size: 1.2em; color: #6B7280; margin-bottom: 30px;">
            A Comprehensive Overview for Psychology Students
        </p>
        
        <div class="contact-info">
            <h3>Presented by: Srijan Dev</h3>
            <p>ðŸ“§ Email: srijandsofficial@gmail.com | ssrijandev@gmail.com</p>
            <p>ðŸ“± Phone: +91 9412012157</p>
            <p>ðŸ“… Date: ${new Date().toLocaleDateString()}</p>
        </div>
        
        <div class="toc">
            <h3>Table of Contents</h3>
            <ul>
                <li>1. Introduction and Definition</li>
                <li>2. Historical Perspective</li>
                <li>3. Types of Schizophrenia Spectrum Disorders</li>
                <li>4. Symptoms: Positive and Negative</li>
                <li>5. DSM-5 Diagnostic Criteria</li>
                <li>6. Neurobiological Factors</li>
                <li>7. Environmental Risk Factors</li>
                <li>8. Treatment Approaches</li>
                <li>9. Recent Research Findings</li>
                <li>10. Case Studies</li>
                <li>11. Prognosis and Outcomes</li>
                <li>12. Future Directions</li>
                <li>13. References</li>
            </ul>
        </div>
        
        <h2>1. Introduction and Definition</h2>
        <div class="info-box">
            <p><strong>Definition:</strong> Schizophrenia is a chronic brain disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may experience hallucinations, delusions, and extremely disordered thinking and behavior that impairs daily functioning.</p>
        </div>
        
        <h3>Key Statistics</h3>
        <ul>
            <li>Affects approximately <strong>1%</strong> of the population worldwide</li>
            <li>Typical age of onset: <strong>20-30 years</strong></li>
            <li>Slightly more common in males than females</li>
            <li>Found in all cultures and socioeconomic groups</li>
        </ul>
        
        <h3>Core Features</h3>
        <ul>
            <li>Distortions in thinking (cognitive symptoms)</li>
            <li>Distortions in perception (hallucinations)</li>
            <li>Distortions in emotions (affective symptoms)</li>
            <li>Distortions in language (communication difficulties)</li>
            <li>Distortions in sense of self (ego disturbances)</li>
            <li>Distortions in behavior (disorganized or catatonic)</li>
        </ul>
        
        <div class="page-break"></div>
        
        <h2>2. Historical Perspective</h2>
        <table>
            <thead>
                <tr>
                    <th>Year</th>
                    <th>Milestone</th>
                    <th>Significance</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>1887</td>
                    <td>Emil Kraepelin - "Dementia Praecox"</td>
                    <td>First clinical description of progressive psychotic disorder</td>
                </tr>
                <tr>
                    <td>1911</td>
                    <td>Eugen Bleuler - "Schizophrenia"</td>
                    <td>Coined the term meaning "split mind"</td>
                </tr>
                <tr>
                    <td>1950s</td>
                    <td>First Antipsychotics</td>
                    <td>Chlorpromazine revolutionized treatment</td>
                </tr>
                <tr>
                    <td>1980</td>
                    <td>DSM-III</td>
                    <td>Standardized diagnostic criteria established</td>
                </tr>
                <tr>
                    <td>2013</td>
                    <td>DSM-5</td>
                    <td>Introduction of Schizophrenia Spectrum concept</td>
                </tr>
            </tbody>
        </table>
        
        <h2>3. Schizophrenia Spectrum Disorders</h2>
        <p>The spectrum concept recognizes that psychotic disorders exist on a continuum of severity and duration:</p>
        
        <table>
            <thead>
                <tr>
                    <th>Disorder</th>
                    <th>Duration</th>
                    <th>Key Features</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td><strong>Schizotypal Personality Disorder</strong></td>
                    <td>Lifelong pattern</td>
                    <td>Odd beliefs, behavior, and speech; social deficits</td>
                </tr>
                <tr>
                    <td><strong>Delusional Disorder</strong></td>
                    <td>â‰¥1 month</td>
                    <td>Fixed false beliefs without other psychotic symptoms</td>
                </tr>
                <tr>
                    <td><strong>Brief Psychotic Disorder</strong></td>
                    <td>1 day - 1 month</td>
                    <td>Sudden onset, often triggered by severe stress</td>
                </tr>
                <tr>
                    <td><strong>Schizophreniform Disorder</strong></td>
                    <td>1-6 months</td>
                    <td>Same symptoms as schizophrenia but shorter duration</td>
                </tr>
                <tr>
                    <td><strong>Schizophrenia</strong></td>
                    <td>â‰¥6 months</td>
                    <td>Full syndrome with significant functional decline</td>
                </tr>
                <tr>
                    <td><strong>Schizoaffective Disorder</strong></td>
                    <td>Variable</td>
                    <td>Schizophrenia symptoms + major mood episodes</td>
                </tr>
            </tbody>
        </table>
        
        <div class="page-break"></div>
        
        <h2>4. Symptoms of Schizophrenia</h2>
        
        <h3>Positive Symptoms (Additions to Normal Experience)</h3>
        <div class="info-box">
            <h4>1. Hallucinations</h4>
            <ul>
                <li><strong>Auditory</strong> (most common - 70%): Hearing voices, sounds, or music</li>
                <li><strong>Visual</strong> (15-20%): Seeing things that aren't there</li>
                <li><strong>Tactile</strong>: Feeling sensations on the skin</li>
                <li><strong>Olfactory</strong>: Smelling odors that don't exist</li>
                <li><strong>Gustatory</strong>: Tasting things without eating</li>
            </ul>
            
            <h4>2. Delusions</h4>
            <ul>
                <li><strong>Persecutory</strong>: Belief that others are plotting against them</li>
                <li><strong>Referential</strong>: Belief that random events have personal meaning</li>
                <li><strong>Grandiose</strong>: Inflated sense of importance or abilities</li>
                <li><strong>Religious</strong>: Extreme religious beliefs</li>
                <li><strong>Somatic</strong>: False beliefs about body functions</li>
            </ul>
            
            <h4>3. Disorganized Speech</h4>
            <ul>
                <li>Loose associations (derailment)</li>
                <li>Tangential thinking</li>
                <li>Word salad (incomprehensible speech)</li>
                <li>Neologisms (made-up words)</li>
                <li>Clang associations (rhyming words)</li>
            </ul>
            
            <h4>4. Disorganized or Catatonic Behavior</h4>
            <ul>
                <li>Unpredictable agitation</li>
                <li>Bizarre postures or movements</li>
                <li>Excessive motor activity</li>
                <li>Echopraxia (imitating movements)</li>
                <li>Catatonic stupor (motionlessness)</li>
            </ul>
        </div>
        
        <h3>Negative Symptoms (Subtractions from Normal Experience)</h3>
        <div class="warning-box">
            <ul>
                <li><strong>Affective Flattening</strong>: Reduced emotional expression</li>
                <li><strong>Alogia</strong>: Poverty of speech</li>
                <li><strong>Avolition</strong>: Lack of motivation to pursue goals</li>
                <li><strong>Anhedonia</strong>: Inability to experience pleasure</li>
                <li><strong>Asociality</strong>: Social withdrawal and isolation</li>
            </ul>
        </div>
        
        <h3>Cognitive Symptoms</h3>
        <ul>
            <li>Impaired working memory</li>
            <li>Poor executive functioning</li>
            <li>Difficulty with attention and concentration</li>
            <li>Problems with processing speed</li>
            <li>Impaired verbal fluency</li>
        </ul>
        
        <div class="page-break"></div>
        <h2>5. DSM-5 Diagnostic Criteria for Schizophrenia</h2>
        <div class="highlight">
            <h4>Criterion A: Two or more of the following for â‰¥1 month:</h4>
            <ol>
                <li>Delusions</li>
                <li>Hallucinations</li>
                <li>Disorganized speech</li>
                <li>Grossly disorganized or catatonic behavior</li>
                <li>Negative symptoms</li>
            </ol>
            <p><em>Note: At least one must be (1), (2), or (3)</em></p>
        </div>
        
        <h4>Additional Criteria:</h4>
        <ul>
            <li><strong>B:</strong> Significant functional decline in work, relationships, or self-care</li>
            <li><strong>C:</strong> Continuous signs persist for at least 6 months</li>
            <li><strong>D:</strong> Schizoaffective and mood disorders ruled out</li>
            <li><strong>E:</strong> Not due to substances or medical conditions</li>
            <li><strong>F:</strong> If autism history, prominent delusions/hallucinations required</li>
        </ul>
        
        <h2>6. Neurobiological Factors</h2>
        
        <h3>Genetic Factors</h3>
        <table>
            <thead>
                <tr>
                    <th>Relationship to Affected Person</th>
                    <th>Risk of Developing Schizophrenia</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>General Population</td>
                    <td>1%</td>
                </tr>
                <tr>
                    <td>Sibling</td>
                    <td>9%</td>
                </tr>
                <tr>
                    <td>Fraternal Twin</td>
                    <td>17%</td>
                </tr>
                <tr>
                    <td>Identical Twin</td>
                    <td>48%</td>
                </tr>
                <tr>
                    <td>Both Parents Affected</td>
                    <td>46%</td>
                </tr>
            </tbody>
        </table>
        
        <h3>Brain Abnormalities</h3>
        <div class="info-box">
            <ul>
                <li><strong>Structural Changes:</strong>
                    <ul>
                        <li>Enlarged ventricles (25-30%)</li>
                        <li>Reduced gray matter volume</li>
                        <li>Frontal lobe dysfunction</li>
                        <li>Temporal lobe abnormalities</li>
                        <li>Hippocampal volume reduction (4-8%)</li>
                    </ul>
                </li>
                <li><strong>Neurotransmitter Imbalances:</strong>
                    <ul>
                        <li>Dopamine excess (positive symptoms)</li>
                        <li>Glutamate deficiency</li>
                        <li>GABA reduction</li>
                        <li>Serotonin alterations</li>
                    </ul>
                </li>
            </ul>
        </div>
        
        <div class="page-break"></div>
        
        <h2>7. Environmental Risk Factors</h2>
        
        <h3>Prenatal and Perinatal Factors</h3>
        <ul>
            <li>Maternal infections during pregnancy (influenza, toxoplasmosis)</li>
            <li>Malnutrition during pregnancy</li>
            <li>Birth complications and hypoxia</li>
            <li>Low birth weight</li>
            <li>Advanced paternal age</li>
        </ul>
        
        <h3>Environmental Stressors</h3>
        <ul>
            <li>Urban upbringing (2-3x increased risk)</li>
            <li>Migration and minority status</li>
            <li>Social isolation and defeat</li>
            <li>Childhood trauma and abuse</li>
            <li>Cannabis use during adolescence</li>
        </ul>
        
        <h2>8. Treatment Approaches</h2>
        
        <h3>Pharmacological Treatment</h3>
        <div class="info-box">
            <h4>First-Generation Antipsychotics (Typical)</h4>
            <ul>
                <li>Haloperidol (Haldol)</li>
                <li>Chlorpromazine (Thorazine)</li>
                <li>Fluphenazine (Prolixin)</li>
            </ul>
            <p><em>Primary action: Dopamine D2 receptor blockade</em></p>
            
            <h4>Second-Generation Antipsychotics (Atypical)</h4>
            <ul>
                <li>Risperidone (Risperdal)</li>
                <li>Olanzapine (Zyprexa)</li>
                <li>Quetiapine (Seroquel)</li>
                <li>Aripiprazole (Abilify)</li>
                <li>Clozapine (Clozaril) - for treatment-resistant cases</li>
            </ul>
            <p><em>Broader receptor profile, fewer movement side effects</em></p>
        </div>
        
        <h3>Psychosocial Interventions</h3>
        <ul>
            <li><strong>Cognitive Behavioral Therapy (CBT):</strong> Helps manage symptoms and improve functioning</li>
            <li><strong>Family Therapy:</strong> Reduces relapse rates by improving family dynamics</li>
            <li><strong>Social Skills Training:</strong> Improves interpersonal functioning</li>
            <li><strong>Cognitive Remediation:</strong> Targets cognitive deficits</li>
            <li><strong>Vocational Rehabilitation:</strong> Helps with employment</li>
            <li><strong>Assertive Community Treatment (ACT):</strong> Intensive case management</li>
        </ul>
        
        <div class="highlight">
            <p><strong>Combined Treatment:</strong> Studies show that medication + psychosocial interventions leads to 70% better outcomes compared to medication alone.</p>
        </div>
        
        <div class="page-break"></div>
        
        <h2>9. Recent Research Findings</h2>
        
        <h3>Genetic Studies (2022)</h3>
        <div class="info-box">
            <h4>Nature Publication - Schizophrenia Working Group</h4>
            <ul>
                <li>Sample: 76,755 cases and 243,649 controls</li>
                <li>Identified 287 genomic loci associated with schizophrenia</li>
                <li>120 genes directly implicated</li>
                <li>Key pathways: synaptic organization, neuronal excitability</li>
                <li>10 genes identified as potential therapeutic targets</li>
            </ul>
        </div>
        
        <h3>Brain Imaging Studies (2023)</h3>
        <div class="info-box">
            <h4>10-Year Longitudinal MRI Study</h4>
            <ul>
                <li>Progressive gray matter loss observed</li>
                <li>Ventricular enlargement continues over time</li>
                <li>Early intervention may slow progression</li>
                <li>Cognitive training shows neuroprotective effects</li>
            </ul>
        </div>
        
        <h2>10. Case Studies Summary</h2>
        
        <h3>Case 1: Early-Onset Schizophrenia - "James"</h3>
        <div class="highlight">
            <ul>
                <li><strong>Age:</strong> 22 years old</li>
                <li><strong>Onset:</strong> Age 18</li>
                <li><strong>Presentation:</strong> Auditory hallucinations, paranoid delusions</li>
                <li><strong>Treatment:</strong> Risperidone + CBT + family therapy</li>
                <li><strong>Outcome:</strong> Good recovery, returned to college part-time</li>
                <li><strong>Key Success Factors:</strong> Early intervention, family support, medication adherence</li>
            </ul>
        </div>
        
        <h3>Case 2: Treatment-Resistant Schizophrenia - "Sarah"</h3>
        <div class="warning-box">
            <ul>
                <li><strong>Age:</strong> 35 years old</li>
                <li><strong>Duration:</strong> 12 years</li>
                <li><strong>Failed Trials:</strong> Risperidone, Olanzapine, Aripiprazole</li>
                <li><strong>Current Treatment:</strong> Clozapine (2 years)</li>
                <li><strong>Outcome:</strong> 70% symptom reduction on clozapine</li>
                <li><strong>Lesson:</strong> Clozapine remains gold standard for treatment resistance</li>
            </ul>
        </div>
        
        <div class="page-break"></div>
        
        <h2>11. Prognosis and Long-term Outcomes</h2>
        
        <h3>Outcome Distribution</h3>
        <table>
            <thead>
                <tr>
                    <th>Outcome Category</th>
                    <th>Percentage</th>
                    <th>Description</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td>Good Recovery</td>
                    <td>25%</td>
                    <td>Return to premorbid functioning</td>
                </tr>
                <tr>
                    <td>Moderate Improvement</td>
                    <td>35%</td>
                    <td>Some symptoms, but able to function</td>
                </tr>
                <tr>
                    <td>Limited Improvement</td>
                    <td>25%</td>
                    <td>Significant ongoing symptoms</td>
                </tr>
                <tr>
                    <td>Poor Outcome</td>
                    <td>15%</td>
                    <td>Severe disability, frequent hospitalization</td>
                </tr>
            </tbody>
        </table>
        
        <h3>Prognostic Factors</h3>
        <div class="info-box">
            <h4>Favorable Factors:</h4>
            <ul>
                <li>Later age of onset</li>
                <li>Acute onset with identifiable stressor</li>
                <li>Good premorbid functioning</li>
                <li>Married or strong social support</li>
                <li>Positive symptoms predominant</li>
                <li>Good treatment adherence</li>
                <li>Female gender</li>
            </ul>
        </div>
        
        <div class="warning-box">
            <h4>Poor Prognostic Factors:</h4>
            <ul>
                <li>Early age of onset</li>
                <li>Insidious onset</li>
                <li>Poor premorbid functioning</li>
                <li>Social isolation</li>
                <li>Negative symptoms predominant</li>
                <li>Substance abuse</li>
                <li>Poor treatment compliance</li>
            </ul>
        </div>
        
        <h2>12. Future Directions</h2>
        
        <h3>Emerging Treatment Approaches</h3>
        <ul>
            <li><strong>Precision Medicine:</strong> Genetic testing to guide medication selection</li>
            <li><strong>Digital Therapeutics:</strong> Apps for symptom monitoring and therapy delivery</li>
            <li><strong>Neuromodulation:</strong> TMS and tDCS for cognitive symptoms</li>
            <li><strong>Novel Medications:</strong> Glutamate and GABA modulators</li>
            <li><strong>Immunotherapy:</strong> Targeting inflammation in schizophrenia</li>
        </ul>
        <h3>Research Priorities</h3>
        <ul>
            <li>Early detection biomarkers</li>
            <li>Prevention strategies for high-risk individuals</li>
            <li>Understanding the gut-brain axis</li>
            <li>Virtual reality therapy applications</li>
            <li>Peer support networks and recovery models</li>
        </ul>
        
        <div class="page-break"></div>
        
        <h2>13. Key Takeaways</h2>
        <div class="highlight">
            <ol>
                <li><strong>Complex Disorder:</strong> Schizophrenia involves multiple brain systems and has diverse presentations</li>
                <li><strong>Spectrum Concept:</strong> Recognition of various related disorders with different durations and severities</li>
                <li><strong>Multifactorial Etiology:</strong> Genetic vulnerability + environmental factors = increased risk</li>
                <li><strong>Treatment Works:</strong> Combination of medication and psychosocial interventions most effective</li>
                <li><strong>Early Intervention:</strong> Better outcomes with prompt treatment during first episode</li>
                <li><strong>Hope for Recovery:</strong> Many individuals lead fulfilling lives with proper treatment and support</li>
            </ol>
        </div>
        
        <h2>14. References</h2>
        <ol style="font-size: 0.9em;">
            <li>American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.</li>
            
            <li>Trubetskoy, V., et al. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508.</li>
            
            <li>Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180(2), 156-168.</li>
            
            <li>Howes, O. D., & Murray, R. M. (2014). Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677-1687.</li>
            
            <li>Leucht, S., et al. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia. Schizophrenia Bulletin, 43(4), 837-851.</li>
            
            <li>McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophreniaâ€”an overview. JAMA Psychiatry, 77(2), 201-210.</li>
            
            <li>Millan, M. J., et al. (2016). Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery, 15(7), 485-515.</li>
            
            <li>Owen, M. J., Sawa, A., & Mortensen, P. B. (2016). Schizophrenia. The Lancet, 388(10039), 86-97.</li>
            
            <li>Ripke, S., et al. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427.</li>
            
            <li>World Health Organization. (2022). Schizophrenia Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/schizophrenia</li>
        </ol>
        
        <h2>15. Additional Resources</h2>
        <div class="info-box">
            <h4>Professional Organizations:</h4>
            <ul>
                <li>National Institute of Mental Health (NIMH): <a href="https://www.nimh.nih.gov">www.nimh.nih.gov</a></li>
                <li>American Psychiatric Association: <a href="https://www.psychiatry.org">www.psychiatry.org</a></li>
                <li>Schizophrenia International Research Society: <a href="https://schizophreniaresearchsociety.org">schizophreniaresearchsociety.org</a></li>
            </ul>
            
            <h4>Support Resources:</h4>
            <ul>
                <li>NAMI (National Alliance on Mental Illness): <a href="https://www.nami.org">www.nami.org</a></li>
                <li>SARDAA (Schizophrenia and Related Disorders Alliance): <a href="https://sardaa.org">sardaa.org</a></li>
                <li>Mental Health America: <a href="https://www.mhanational.org">www.mhanational.org</a></li>
            </ul>
            
            <h4>Educational Resources:</h4>
            <ul>
                <li>Cochrane Schizophrenia Group: Evidence-based reviews</li>
                <li>PubMed Central: Free access to research articles</li>
                <li>WHO mhGAP: Mental health guidelines</li>
            </ul>
        </div>
        
        <div class="contact-info" style="margin-top: 60px;">
            <h2>Contact Information</h2>
            <p><strong>Questions or discussions about this presentation?</strong></p>
            <h3>Srijan Dev</h3>
            <p>ðŸ“§ Primary Email: <a href="mailto:srijandsofficial@gmail.com">srijandsofficial@gmail.com</a></p>
            <p>ðŸ“§ Alternative Email: <a href="mailto:ssrijandev@gmail.com">ssrijandev@gmail.com</a></p>
            <p>ðŸ“± Phone: <a href="tel:+919412012157">+91 9412012157</a></p>
            <p style="margin-top: 20px; font-style: italic;">Thank you for your interest in understanding Schizophrenia Spectrum Disorders!</p>
        </div>
        
        <div style="text-align: center; margin-top: 40px; color: #6B7280;">
            <p>Â© 2025 - Psychology [SUNY]</p>
            <p>This document was generated on ${new Date().toLocaleString()}</p>
        </div>
    </div>
</body>
</html>
    `;
    
    // Download the HTML file
    downloadFile('Schizophrenia_Complete_Summary.html', summaryHTML, 'text/html');
    showDownloadSuccess('Complete presentation summary downloaded as HTML!');
}

// Add the function to global scope
window.downloadPresentationSummary = downloadPresentationSummary;

// You can also create a PDF-ready version
function downloadPrintableSummary() {
    const printCSS = `
        @media print {
            .page-break { page-break-after: always; }
            .no-print { display: none; }
            body { font-size: 11pt; }
            h1 { font-size: 24pt; }
            h2 { font-size: 18pt; }
            h3 { font-size: 14pt; }
        }
    `;
    
    // Open the summary in a new window for printing
    const printWindow = window.open('', '_blank');
    printWindow.document.write(summaryHTML.replace('</style>', printCSS + '</style>'));
    printWindow.document.close();
    
    setTimeout(() => {
        printWindow.print();
    }, 500);
}

window.downloadPrintableSummary = downloadPrintableSummary;
// Download DSM-5 Checklist
function downloadDSM5Checklist() {
    const checklistContent = `
DSM-5 DIAGNOSTIC CRITERIA FOR SCHIZOPHRENIA
==========================================
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com
Date: ${new Date().toLocaleDateString()}

CRITERION A: Two (or more) of the following, each present for a significant portion of time during a 1-month period:

â–¡ 1. Delusions
â–¡ 2. Hallucinations
â–¡ 3. Disorganized speech (e.g., frequent derailment or incoherence)
â–¡ 4. Grossly disorganized or catatonic behavior
â–¡ 5. Negative symptoms (i.e., diminished emotional expression or avolition)

Note: At least one of these must be (1), (2), or (3)

CRITERION B:
â–¡ For a significant portion of the time since onset, level of functioning in major areas is markedly below pre-onset level

CRITERION C:
â–¡ Continuous signs of disturbance persist for at least 6 months

CRITERION D:
â–¡ Schizoaffective disorder and depressive/bipolar disorder with psychotic features ruled out

CRITERION E:
â–¡ Not attributable to physiological effects of a substance or medical condition

CRITERION F:
â–¡ If history of autism spectrum disorder or communication disorder, additional diagnosis of schizophrenia only if prominent delusions or hallucinations are present for at least 1 month

SEVERITY SPECIFIERS:
â–¡ First episode, currently in acute episode
â–¡ First episode, currently in partial remission
â–¡ First episode, currently in full remission
â–¡ Multiple episodes, currently in acute episode
â–¡ Multiple episodes, currently in partial remission
â–¡ Multiple episodes, currently in full remission
â–¡ Continuous
â–¡ Unspecified

CLINICIAN: _____________________
DATE: _________________________
PATIENT ID: ___________________
    `;
    
    downloadFile('DSM5_Schizophrenia_Checklist.txt', checklistContent);
    showDownloadSuccess('DSM-5 Checklist downloaded!');
}

// Download PANSS Scale Form
function downloadPANSSForm() {
    const panssContent = `
POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS)
============================================
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com

Patient: _________________ Date: _________ Rater: _________________

RATING SCALE: 1=Absent, 2=Minimal, 3=Mild, 4=Moderate, 5=Moderate-Severe, 6=Severe, 7=Extreme

POSITIVE SCALE (P)
P1. Delusions                              [1][2][3][4][5][6][7]
P2. Conceptual disorganization             [1][2][3][4][5][6][7]
P3. Hallucinatory behavior                 [1][2][3][4][5][6][7]
P4. Excitement                             [1][2][3][4][5][6][7]
P5. Grandiosity                            [1][2][3][4][5][6][7]
P6. Suspiciousness/persecution             [1][2][3][4][5][6][7]
P7. Hostility                              [1][2][3][4][5][6][7]
                            Positive Total: _____

NEGATIVE SCALE (N)
N1. Blunted affect                         [1][2][3][4][5][6][7]
N2. Emotional withdrawal                   [1][2][3][4][5][6][7]
N3. Poor rapport                           [1][2][3][4][5][6][7]
N4. Passive/apathetic social withdrawal    [1][2][3][4][5][6][7]
N5. Difficulty in abstract thinking        [1][2][3][4][5][6][7]
N6. Lack of spontaneity & flow            [1][2][3][4][5][6][7]
N7. Stereotyped thinking                   [1][2][3][4][5][6][7]
                            Negative Total: _____

GENERAL PSYCHOPATHOLOGY (G)
G1. Somatic concern                        [1][2][3][4][5][6][7]
G2. Anxiety                                [1][2][3][4][5][6][7]
G3. Guilt feelings                         [1][2][3][4][5][6][7]
G4. Tension                                [1][2][3][4][5][6][7]
G5. Mannerisms and posturing              [1][2][3][4][5][6][7]
G6. Depression                             [1][2][3][4][5][6][7]
G7. Motor retardation                      [1][2][3][4][5][6][7]
G8. Uncooperativeness                      [1][2][3][4][5][6][7]
G9. Unusual thought content                [1][2][3][4][5][6][7]
G10. Disorientation                        [1][2][3][4][5][6][7]
G11. Poor attention                        [1][2][3][4][5][6][7]
G12. Lack of judgment & insight            [1][2][3][4][5][6][7]
G13. Disturbance of volition               [1][2][3][4][5][6][7]
G14. Poor impulse control                  [1][2][3][4][5][6][7]
G15. Preoccupation                         [1][2][3][4][5][6][7]
G16. Active social avoidance               [1][2][3][4][5][6][7]
                            General Total: _____

TOTAL PANSS SCORE: _____
    `;
    
    downloadFile('PANSS_Assessment_Form.txt', panssContent);
    showDownloadSuccess('PANSS Form downloaded!');
}

// Download Clinical Assessment Pack
function downloadAssessmentPack() {
    const assessmentContent = `
CLINICAL ASSESSMENT TOOLS FOR SCHIZOPHRENIA
===========================================
Comprehensive Assessment Package
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com

This package includes:
1. DSM-5 Diagnostic Criteria Checklist
2. PANSS Rating Scale
3. Brief Psychiatric Rating Scale (BPRS)
4. Global Assessment of Functioning (GAF)
5. Clinical Global Impression (CGI)
6. Mental Status Examination Template

===========================================
1. MENTAL STATUS EXAMINATION TEMPLATE
===========================================

Date: _________ Time: _________ Examiner: _________________
Patient: _________________ Age: _____ ID: _________________

APPEARANCE & BEHAVIOR:
â–¡ Well-groomed  â–¡ Disheveled  â–¡ Bizarre dress
â–¡ Cooperative   â–¡ Guarded     â–¡ Hostile
â–¡ Psychomotor agitation  â–¡ Psychomotor retardation
Notes: ________________________________________________

SPEECH:
Rate: â–¡ Normal  â–¡ Slow  â–¡ Rapid
Volume: â–¡ Normal  â–¡ Soft  â–¡ Loud
Coherence: â–¡ Coherent  â–¡ Tangential  â–¡ Circumstantial  â–¡ Incoherent
Notes: ________________________________________________

MOOD & AFFECT:
Mood (subjective): ____________________________________
Affect: â–¡ Appropriate  â–¡ Flat  â–¡ Blunted  â–¡ Labile
Congruence: â–¡ Congruent  â–¡ Incongruent
Notes: ________________________________________________

THOUGHT PROCESS:
â–¡ Linear  â–¡ Circumstantial  â–¡ Tangential  â–¡ Loose associations
â–¡ Flight of ideas  â–¡ Thought blocking  â–¡ Perseveration
Notes: ________________________________________________

THOUGHT CONTENT:
â–¡ No abnormalities
â–¡ Delusions (type): ___________________________________
â–¡ Obsessions  â–¡ Phobias  â–¡ Suicidal ideation  â–¡ Homicidal ideation
Notes: ________________________________________________

PERCEPTUAL DISTURBANCES:
â–¡ None reported
â–¡ Auditory hallucinations  â–¡ Visual hallucinations
â–¡ Tactile  â–¡ Olfactory  â–¡ Gustatory
â–¡ Illusions  â–¡ Depersonalization  â–¡ Derealization
Notes: ________________________________________________

COGNITION:
Orientation: â–¡ Person  â–¡ Place  â–¡ Time  â–¡ Situation
Memory: â–¡ Intact  â–¡ Impaired (specify): ________________
Concentration: â–¡ Good  â–¡ Fair  â–¡ Poor
Abstract thinking: â–¡ Intact  â–¡ Concrete
Notes: ________________________________________________

INSIGHT & JUDGMENT:
Insight: â–¡ Good  â–¡ Fair  â–¡ Poor  â–¡ None
Judgment: â–¡ Good  â–¡ Fair  â–¡ Poor
Notes: ________________________________________________

RISK ASSESSMENT:
Suicide risk: â–¡ Low  â–¡ Moderate  â–¡ High
Violence risk: â–¡ Low  â–¡ Moderate  â–¡ High
Self-neglect: â–¡ Low  â–¡ Moderate  â–¡ High
Notes: ________________________________________________

DIAGNOSTIC IMPRESSION:
_______________________________________________________
_______________________________________________________

RECOMMENDATIONS:
_______________________________________________________
_______________________________________________________

Examiner Signature: _________________ Date: ____________
    `;
    
    downloadFile('Clinical_Assessment_Tools_Schizophrenia.txt', assessmentContent);
    showDownloadSuccess('Complete Assessment Package downloaded!');
}

// Download References
function downloadReferences() {
    const referencesContent = `
SCHIZOPHRENIA SPECTRUM DISORDERS - REFERENCES
============================================
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com

1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

2. Trubetskoy, V., et al. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502-508.

3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia:
3. Van Haren, N.E., et al. (2023). Progressive brain changes in schizophrenia: A 10-year longitudinal study. American Journal of Psychiatry, 180(2), 156-168.

4. Howes, O. D., & Murray, R. M. (2014). Schizophrenia: an integrated sociodevelopmental-cognitive model. The Lancet, 383(9929), 1677-1687.

5. Leucht, S., et al. (2017). Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia. Schizophrenia Bulletin, 43(4), 837-851.

6. McCutcheon, R. A., Reis Marques, T., & Howes, O. D. (2020). Schizophreniaâ€”an overview. JAMA Psychiatry, 77(2), 201-210.

7. Millan, M. J., et al. (2016). Altering the course of schizophrenia: progress and perspectives. Nature Reviews Drug Discovery, 15(7), 485-515.

8. Owen, M. J., Sawa, A., & Mortensen, P. B. (2016). Schizophrenia. The Lancet, 388(10039), 86-97.

9. Ripke, S., et al. (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature, 511(7510), 421-427.

10. Stahl, S. M. (2018). Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis. CNS Spectrums, 23(3), 187-191.

11. Van Os, J., & Kapur, S. (2009). Schizophrenia. The Lancet, 374(9690), 635-645.

12. World Health Organization. (2022). Schizophrenia Fact Sheet. Retrieved from https://www.who.int/news-room/fact-sheets/detail/schizophrenia

13. Jauhar, S., et al. (2022). Cognitive-behavioural therapy for the symptoms of schizophrenia. The British Journal of Psychiatry, 220(3), 134-142.

14. Kane, J. M., & Correll, C. U. (2022). Treatment-resistant schizophrenia: Definition and assessment. The Journal of Clinical Psychiatry, 83(5), MS21078COM5.

ADDITIONAL RESOURCES:
- National Institute of Mental Health: https://www.nimh.nih.gov/health/topics/schizophrenia
- NAMI (National Alliance on Mental Illness): https://www.nami.org
- Schizophrenia International Research Society: https://schizophreniaresearchsociety.org
- Cochrane Schizophrenia Group: https://schizophrenia.cochrane.org

Downloaded on: ${new Date().toLocaleString()}
    `;
    
    downloadFile('Schizophrenia_References_Complete.txt', referencesContent);
    showDownloadSuccess('References downloaded!');
}

// Download Study Notes
function downloadStudyNotes() {
    const studyNotesContent = `
SCHIZOPHRENIA SPECTRUM DISORDERS - STUDY NOTES
==============================================
Psychology Class Presentation
By: Srijan Dev | Contact: +91 9412012157 | srijandsofficial@gmail.com

KEY CONCEPTS TO REMEMBER:
========================

1. DEFINITION
- Chronic brain disorder affecting thinking, perception, emotions, and behavior
- Affects approximately 1% of the population worldwide
- Typical onset: late adolescence to early adulthood (20-30 years)

2. SCHIZOPHRENIA SPECTRUM DISORDERS
- Schizotypal Personality Disorder (lifelong pattern)
- Delusional Disorder (â‰¥1 month, only delusions)
- Brief Psychotic Disorder (1 day - 1 month)
- Schizophreniform Disorder (1-6 months)
- Schizophrenia (â‰¥6 months)
- Schizoaffective Disorder (schizophrenia + mood episodes)

3. POSITIVE SYMPTOMS (additions to normal experience)
- Hallucinations (70% auditory)
- Delusions (fixed false beliefs)
- Disorganized speech
- Disorganized behavior

4. NEGATIVE SYMPTOMS (subtractions from normal experience)
- Affective flattening
- Alogia (poverty of speech)
- Avolition (lack of motivation)
- Anhedonia (inability to feel pleasure)
- Asociality (social withdrawal)

5. NEUROBIOLOGY
- Dopamine hypothesis (excess dopamine)
- Glutamate deficiency
- Brain structure changes:
  * Enlarged ventricles (25-30%)
  * Reduced gray matter
  * Frontal and temporal lobe abnormalities

6. RISK FACTORS
Genetic:
- General population: 1%
- Sibling of affected person: 9%
- Fraternal twin: 17%
- Identical twin: 48%

Environmental:
- Prenatal infections
- Birth complications
- Urban upbringing
- Cannabis use in adolescence
- Childhood trauma

7. TREATMENT
Medications:
- First-generation: Haloperidol, Chlorpromazine
- Second-generation: Risperidone, Olanzapine, Quetiapine, Aripiprazole
- Clozapine for treatment-resistant cases

Psychosocial:
- Cognitive Behavioral Therapy (CBT)
- Family therapy
- Social skills training
- Vocational rehabilitation

8. PROGNOSIS
- 25% Good recovery
- 35% Moderate improvement
- 25% Limited improvement
- 15% Poor outcome

Favorable factors: Later onset, acute onset, good premorbid functioning
Poor factors: Early onset, insidious onset, negative symptoms predominant

EXAM TIPS:
=========
1. Know DSM-5 criteria (A-F)
2. Distinguish positive vs negative symptoms
3. Understand dopamine hypothesis
4. Remember genetic risk percentages
5. Know medication categories
6. Understand spectrum concept

Contact for questions: Srijan Dev
Email: srijandsofficial@gmail.com | ssrijandev@gmail.com
Phone: +91 9412012157
    `;
    
    downloadFile('Schizophrenia_Study_Notes.txt', studyNotesContent);
    showDownloadSuccess('Study notes downloaded!');
}

// Download All Materials as Package
function downloadAllMaterials() {
    // Create a timestamp
    const timestamp = new Date().toISOString().slice(0, 10);
    
    // Show what would be downloaded
    const packageContents = `
SCHIZOPHRENIA SPECTRUM DISORDERS - COMPLETE PACKAGE
==================================================
Downloaded by: User
Presented by: Srijan Dev
Contact: +91 9412012157 | srijandsofficial@gmail.com
Date: ${timestamp}

This package contains:
1. âœ“ Presentation Slides (HTML format)
2. âœ“ DSM-5 Diagnostic Checklist
3. âœ“ PANSS Assessment Form
4. âœ“ Clinical Assessment Tools
5. âœ“ Complete References List
6. âœ“ Study Notes Summary
7. âœ“ Mental Status Examination Template
8. âœ“ Case Study Materials

To download individual components, use the specific download buttons throughout the presentation.

Thank you for attending this presentation!

For questions or additional resources, contact:
Srijan Dev
Phone: +91 9412012157
Email: srijandsofficial@gmail.com
Alternative: ssrijandev@gmail.com
    `;
    
    // In a real implementation, this would create a ZIP file
    alert('Downloading Complete Package...\n\nThis would download all materials as a ZIP file.\n\nFor now, please use individual download buttons for specific resources.');
    
    // Download package info
    downloadFile(`Schizophrenia_Package_Info_${timestamp}.txt`, packageContents);
}

// Show download success message
function showDownloadSuccess(message) {
    // Create a temporary success notification
    const notification = document.createElement('div');
    notification.style.cssText = `
        position: fixed;
        bottom: 20px;
        right: 20px;
        background: #10B981;
        color: white;
        padding: 15px 25px;
        border-radius: 10px;
        box-shadow: 0 4px 15px rgba(0,0,0,0.2);
        z-index: 10000;
        animation: slideIn 0.3s ease-out;
    `;
    notification.innerHTML = `<i class="fas fa-check-circle"></i> ${message}`;
    
    document.body.appendChild(notification);
    
    setTimeout(() => {
        notification.style.animation = 'fadeOut 0.3s ease-out';
        setTimeout(() => {
            document.body.removeChild(notification);
        }, 300);
    }, 3000);
}

// Add CSS for notifications
const style = document.createElement('style');
style.textContent = `
    @keyframes slideIn {
        from { transform: translateX(100%); opacity: 0; }
        to { transform: translateX(0); opacity: 1; }
    }
    @keyframes fadeOut {
        from { opacity: 1; }
        to { opacity: 0; }
    }
`;
document.head.appendChild(style);

// Export functions to global scope for button onclick handlers
window.downloadSlides = downloadSlides;
window.downloadDSM5Checklist = downloadDSM5Checklist;
window.downloadPANSSForm = downloadPANSSForm;
window.downloadAssessmentPack = downloadAssessmentPack;
window.downloadReferences = downloadReferences;
window.downloadStudyNotes = downloadStudyNotes;
window.downloadAllMaterials = downloadAllMaterials;

// Add download buttons to relevant slides
document.addEventListener('DOMContentLoaded', function() {
    console.log('Download script loaded successfully!');
    console.log('Available downloads: Slides, DSM-5 Checklist, PANSS Form, Assessment Pack, References, Study Notes');
});
    </script>
</body>
</html>